Introduction {#s1}
============

Among the oxidants available for biological reduction, molecular oxygen (O~2~) provides the highest free energy yield. Since the accumulation of O~2~ in the atmosphere between \~2.4 and 0.54 billion years ago ([@bib38]; [@bib20]), organisms that can use it for growth and survival, and tolerate its harmful byproducts, have evolved to exploit this energy and increased in complexity ([@bib39]; [@bib24]). At small scales and in crowded environments, rapid consumption of O~2~ leads to competition for this resource and has promoted diversification of bacterial and archaeal mechanisms for O~2~ reduction that has not occurred in eukaryotes ([@bib8]). The various enzymes that allow bacteria to respire O~2~ exhibit a range of affinities and proton-pumping efficiencies and likely contribute to competitive success in hypoxic niches ([@bib42]). Such environments include the tissues of animal and plant hosts that are colonized by bacteria of high agricultural ([@bib49]) and clinical ([@bib64]; [@bib65]) significance.

The opportunistic pathogen *Pseudomonas aeruginosa*, a colonizer of both plant and animal hosts ([@bib51]), has a branched respiratory chain with the potential to reduce O~2~ to water using five canonical terminal oxidase complexes: two quinol oxidases (*bo*~3~ (Cyo) and a *bd*-type cyanide-insensitive oxidase (CIO)) and three cytochrome *c* oxidases (*aa*~3~ (Cox), *cbb*~3~-1 (Cco1), and *cbb*~3~-2 (Cco2)) ([Figure 1A](#fig1){ref-type="fig"}). Several key publications have described *P. aeruginosa*'s complement of terminal oxidases and oxidase subunits, revealing features specific to this organism ([@bib67]; [@bib10]; [@bib1]; [@bib3]; [@bib34]; [@bib33]). *P. aeruginosa* is unusual in that it encodes two oxidases belonging to the *cbb*~3~-type family. These enzymes are notable for their relatively high catalytic activity at low O~2~ concentrations and restriction to the bacterial domain ([@bib8]; [@bib47]). (The *P. aeruginosa cbb*~3~-type oxidases are often referred to as *cbb*~3~*-*1 and *cbb*~3~-2; however, we will use 'Cco1' and 'Cco2' for these enzymes, consistent with the annotations of their encoding genes.) Most bacterial genomes that encode *cbb*~3~-type oxidases contain only one operon for such a complex, which is induced specifically under conditions of O~2~ limitation ([@bib11]). In *P. aeruginosa*, the *cco2* operon is induced during growth at low O~2~ concentrations, but the *cco1* operon is expressed constitutively at high levels ([@bib10]; [@bib34]).

![The respiratory chain and arrangement of *cco* genes and protein products in *P. aeruginosa*, and the phylogenetic distribution of orphan *ccoN* genes.\
(**A**) Branched electron transport chain in *P. aeruginosa*, containing five canonical terminal oxidases. (**B**) Organization of *cco* genes in the *P. aeruginosa* genome. The cartoon of the Cco complex is based on the Cco structure from *P. stutzeri* (PDB: 3mk7) ([@bib9]). (**C**) Left: graphical representation of the portion of genomes in each bacterial phylum that contain *ccoO* and *N* homologs. The clades Chrysiogenetes, Gemmatimonadetes, and Zetaproteobacteria were omitted because they each contain only one species with *ccoO* and *N* homologs. The height of each rectangle indicates the total number of genomes included in the analysis. The width of each shaded rectangle represents the portion of genomes that contain *ccoN* homologs. Middle: genomes that contain more *ccoN* than *ccoO* homologs (indicating the presence of orphan *ccoN* genes) are listed. Right: numbers of *ccoO* and *ccoN* homologs in each genome. Blue highlights genomes containing more than one orphan *ccoN* homolog.](elife-30205-fig1){#fig1}

An additional quirk of the *P. aeruginosa* terminal oxidase complement lies in the presence of genes for 'orphan' *cbb*~3~-type subunits at chromosomal locations distinct from the *cco1* and *cco2* operons. While the *cco1* and *cco2* operons, which are chromosomally adjacent, each contain four genes encoding a functional Cco complex (consisting of subunits N, O, P, and Q), the two additional partial operons *ccoN3Q3* and *ccoN4Q4* each contain homologs coding for only the Q and catalytic N subunits ([Figure 1B](#fig1){ref-type="fig"}). Expression of the *ccoN3Q3* operon is induced under anaerobic denitrification conditions ([@bib1]), and by nitrite exposure during growth under 2% O~2~ ([@bib29]). During aerobic growth in liquid cultures, *ccoN4Q4* is induced by cyanide, which is produced in stationary phase ([@bib29]). However, additional expression studies indicate that *ccoN4Q4* transcription is influenced by redox conditions, as this operon is induced by O~2~ limitation ([@bib1]) and slightly downregulated in response to pyocyanin, a redox-active antibiotic produced by *P. aeruginosa* ([@bib18]).

In a recent study, Hirai *et al*. characterized the biochemical properties and physiological roles of *P. aeruginosa cbb*~3~ isoforms containing combinations of canonical and orphan subunits ([@bib29]). In a strain lacking all of the aerobic terminal oxidases, expression of any isoform conferred the ability to grow using O~2~, confirming that isoforms containing the orphan N subunits are functional. When preparations from wild-type, stationary-phase *P. aeruginosa* cells were separated on 2D gels and probed with anti-CcoN4 antibody, this subunit was detected at the same position as the assembled CcoNOP complex, showing that CcoN4-containing heterocomplexes form in vivo. Furthermore, the authors found that the products of *ccoN3Q3* and *ccoN4Q4* contributed resistance to nitrite and cyanide, respectively, during growth in liquid cultures under low-O~2~ conditions. While these results provide insight into contributions of the *cbb*~3~ heterocomplexes to growth in liquid cultures, potential roles for N3- and N4-containing isoforms in biofilm growth and pathogenicity have yet to be explored.

The biofilm lifestyle---in which cells grow in a dense community encased in a self-produced matrix---has been linked to the establishment and persistence of infections in diverse systems ([@bib22]; [@bib55]). Biofilm development promotes the formation of O~2~ gradients such that cells at a distance from the biofilm surface are subjected to hypoxic or anoxic conditions ([@bib66]). Using a colony morphology assay to study redox metabolism and its relationship to community behavior, we have shown that O~2~ limitation for cells in biofilms leads to an imbalance in the intracellular redox state. This can be relieved by a change in community morphology, which increases the surface area-to-volume ratio of the biofilm and therefore access to O~2~ for resident cells ([@bib36]). For *P. aeruginosa* cells in biofilms, the intracellular accumulation of reducing power can also be prevented by production and reduction of endogenous antibiotics called phenazines, which mediate extracellular electron transfer to oxidants available at a distance ([@bib17]). We have found that biofilm-specific phenazine production contributes to pathogenicity in a murine model of acute pulmonary infection ([@bib53]), further illustrating the importance of phenazine-mediated redox balancing for *P. aeruginosa* cells in communities.

Because of the formation of an O~2~ gradient inherent to the biofilm lifestyle, we hypothesized that the differential regulation of the *P. aeruginosa cco* operons affects their contributions to metabolic electron flow in biofilm subzones. We evaluated the roles of various *cbb*~3~-type oxidase isoforms in multicellular behavior and virulence. Our results indicate that isoforms containing the orphan subunit CcoN4 can support survival in biofilms via O~2~ and phenazine reduction and contribute to *P. aeruginosa* pathogenicity in a *Caenorhabditis elegans* 'slow killing' model of infection.

Results {#s2}
=======

A small minority of bacterial genomes encode *cbb*~3~-type oxidase subunits in partial ('orphan') operons {#s2-1}
---------------------------------------------------------------------------------------------------------

Biochemical, genetic, and genomic analyses suggest that the CcoN and CcoO subunits, typically encoded by an operon, form the minimal functional unit of *cbb*~3~-type oxidases ([@bib21]; [@bib15]; [@bib69]). CcoN is the membrane-integrated catalytic subunit and contains two *b*-type hemes and a copper ion. CcoO is membrane-anchored and contains one *c*-type heme. Additional redox subunits and/or subunits implicated in complex assembly, such as CcoQ and CcoP, can be encoded by adjacent genes ([Figure 1B](#fig1){ref-type="fig"}). *ccoNO*-containing clusters are widely distributed across phyla of the bacterial domain ([@bib21]). We used the EggNOG database, which contains representative genomes for more than 3000 bacterial species ([@bib31]) to obtain an overview of the presence and frequency of *cco* genes. Out of 3318 queried bacterial genomes, we found 467 with full *cco* operons (encoding potentially functional *cbb*~3~-type oxidases with O and N subunits). Among these, 78 contain more than one full operon. We also used EggNOG to look for orphan *ccoN* genes by examining the relative numbers of *ccoO* and *ccoN* homologs in individual genomes. We found 14 genomes, among which *Pseudomonas* species are overrepresented, that contain orphan *ccoN* genes ([Figure 1C](#fig1){ref-type="fig"}), and our analysis yielded three species that contain more than one orphan *ccoN* gene: *Pseudomonas mendocina*, *Pseudomonas aeruginosa*, and *Achromobacter xylosoxidans. P. mendocina* is a soil bacterium and occasional nosocomial pathogen that is closely related to *P. aeruginosa*, based on 16S rRNA gene sequence comparison ([@bib2]). *A. xylosoxidans*, in contrast, is a member of a different proteobacterial class but nevertheless is often mistaken for *P. aeruginosa* ([@bib56]). Like *P. aeruginosa*, it is an opportunistic pathogen that can cause pulmonary infections in immunocompromised individuals and patients with cystic fibrosis ([@bib14]; [@bib25]). Hirai *et al*. previously reported a ClustalW-based analysis of CcoN homologs specifically from pseudomonads, which indicated the presence of orphan genes in additional species not represented in the EggNOG database. These include *P. denitrificans*, which contains two orphan genes ([@bib29]).

CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration {#s2-2}
--------------------------------------------------------------------------------------------------------------

During growth in a biofilm, subpopulations of cells are subjected to regimes of electron donor and O~2~ availability that may create unique metabolic demands and require modulation of the respiratory chain for survival ([@bib1]; [@bib7]; [@bib66]). We therefore investigated the contributions of individual *cco* genes and gene clusters to *P. aeruginosa* PA14 biofilm development using a colony morphology assay, which has demonstrated sensitivity to electron acceptor availability and utilization ([@bib17]). Because the Cco1 and Cco2 complexes are the most important cytochrome oxidases for growth of *P. aeruginosa* in fully aerated and O~2~-limited liquid cultures ([@bib1]; [@bib3]), we predicted that mutations disabling the functions of Cco1 and Cco2 would affect colony growth. Indeed, a mutant lacking both the *cco1* and *cco2* operons ('∆*cco1cco2*') produced thin biofilms with a smaller diameter than the wild type. After 5 days of development, this mutant displayed a dramatic phenotype consisting of a tall central ring feature surrounded by short ridges that emanate radially ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). ∆*cco1cco2* colonies were also darker in color, indicating increased uptake of the dye Congo red, which binds to the extracellular matrix produced by biofilms ([@bib26]). Surprisingly, a strain specifically lacking the catalytic subunits of Cco1 and Cco2 ('∆*N1*∆*N2*'), while showing a growth defect similar to that of *∆cco1cco2* when grown in liquid culture ([Figure 2C](#fig2){ref-type="fig"}), showed biofilm development that was similar to that of the wild type ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}).

![CcoN4-containing heterocomplexes make biofilm-specific contributions to morphogenesis and respiration.\
(**A**) Top: Five-day-old colony biofilms of PA14 WT and *cco* mutant strains. Biofilm morphologies are representative of more than 10 biological replicates. Images were generated using a digital microscope. Scale bar is 1 cm. Bottom: 3D surface images of the biofilms shown in the top panel. Images were generated using a wide-area 3D measurement system. Height scale bar: bottom (blue) to top (red) is 0--0.7 mm for WT, ∆*N1*∆*N2*, and ∆*N4*; 0--1.5 mm for ∆*N1*∆*N2*∆*N4* and ∆*cco1cco2*. (**B**) TTC reduction by WT and *cco* mutant colonies after 1 day of growth. Upon reduction, TTC undergoes an irreversible color change from colorless to red. Bars represent the average, and error bars represent the standard deviation, of individually-plotted biological replicates (n = 5). p-Values were calculated using unpaired, two-tailed t tests comparing each mutant to WT (\*\*\*\*p≤0.0001). (**C**) Mean growth of PA14 WT and *cco* mutant strains in MOPS defined medium with 20 mM succinate. Error bars represent the standard deviation of biological triplicates.](elife-30205-fig2){#fig2}

As it is known that CcoN3 and CcoN4 can form functional complexes with subunits of the Cco1 and Cco2 oxidases in *P. aeruginosa* PAO1 ([@bib29]), this led us to hypothesize that Cco isoforms containing the orphan subunits CcoN3 and/or CcoN4 could substitute for Cco1 and Cco2 in the biofilm context. Deleting *ccoN3* ('∆*N3*' or '∆*N1*∆*N2*∆*N3*') did not have an observable effect on biofilm development when mutants were compared to respective parent strains ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). However, the phenotype of a '∆*N1*∆*N2∆N4*' mutant was consistent with our model, as it mimicked that of the ∆*cco1cco2* mutant in both liquid-culture and biofilm growth ([Figure 2A and C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Furthermore, we found that a mutant lacking only *ccoN4* ('∆*N4*') displayed an altered phenotype in that it began to form wrinkle structures earlier than the wild type ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), which developed into a disordered region of wrinkles inside a central ring, surrounded by long, radially emanating ridges ([Figure 2A](#fig2){ref-type="fig"}). Reintroduction of the *ccoN4* gene into either of these strains restored the phenotypes of the respective parent strains ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Deletion of either *ccoN2* or *ccoN3* in the ∆*N4* background did not exacerbate the colony phenotype seen in ∆*N4* alone. However, the '∆*N1*∆*N4*' double mutant showed an intermediate phenotype relative to ∆*N4* and ∆*N1*∆*N2*∆*N4* ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), suggesting some functional redundancy for CcoN1 and CcoN4. The developmental pattern of the ∆*N4* colony is reminiscent of those displayed by mutants defective in phenazine production and sensing ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) ([@bib19]; [@bib17]; [@bib57]; [@bib45]). Although ∆*N4* itself showed a unique phenotype in the colony morphology assay, its growth in shaken liquid cultures was indistinguishable from that of the wild type ([Figure 2C](#fig2){ref-type="fig"}). Finally, deleting the three non-*cbb*~3~-type terminal oxidases ('∆*cox*∆*cyo*∆*cio*'), did not affect biofilm morphology ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). These results suggest that CcoN4-containing Cco isoforms play physiological roles that are specific to the growth conditions encountered in biofilms.

Next, we asked whether CcoN4 contributes to respiration in biofilms. We tested a suite of *cco* mutants for reduction of triphenyl tetrazolium chloride (TTC), an activity that is associated with cytochrome *c* oxidase-dependent respiration ([@bib54]). The ∆*cco1cco2* mutant showed a severe defect in TTC reduction, which was recapitulated by the ∆*N1*∆*N2∆N4* mutant. As in the colony morphology assay, this extreme phenotype was not recapitulated in a mutant lacking only CcoN1 and CcoN2, indicating that CcoN4 contributes to respiratory activity in PA14 biofilms. Although we did not detect a defect in TTC reduction for the ∆*N4* mutant, we saw an intermediate level of TTC reduction for ∆*N1*∆*N4* compared to ∆*N1*∆*N2* and ∆*N1*∆*N2∆N4*, further implicating the CcoN4 subunit in this activity ([Figure 2B](#fig2){ref-type="fig"}).

A recent study demonstrated a role for CcoN4 in resistance to cyanide, a respiratory toxin that is produced by *P. aeruginosa* ([@bib29]). The altered biofilm phenotypes of ∆*N4* mutants could therefore be attributed to an increased sensitivity to cyanide produced during biofilm growth. We deleted the *hcn* operon, coding for cyanide biosynthetic enzymes, in wild-type, phenazine-null (∆*phz*), and various *cco* mutant backgrounds. The biofilm morphologies and liquid-culture growth of these strains were unaffected by the ∆*hcnABC* mutation, indicating that the biofilm-specific role of CcoN4 explored in this work is independent of its role in mediating cyanide resistance ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Additionally, we examined genomes available in the Pseudomonas Genome Database for the presence of homologs encoding CcoN subunits (*ccoN* genes) and enzymes for cyanide synthesis (*hcnABC*) ([@bib68]) and did not find a clear correlation between the presence of *hcnABC* and *ccoN4* homologs ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

Together, the effects of *cco* gene mutations that we observed in assays for colony morphogenesis and TTC reduction suggest that one or more CcoN4-containing Cco isoform(s) support respiration and redox balancing, and is/are utilized preferentially in comparison to CcoN1- and CcoN2-containing Cco complexes, in biofilms. We performed a sequence alignment of the CcoN subunits encoded by the PA14 genome and identified residues that are unique to CcoN4 or shared uniquely between CcoN4 and CcoN1, which showed the strongest functional redundancy with CcoN4 in our assays ([Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}). We also threaded the CcoN4 sequence using the available structure of the CcoN subunit from *P. stutzeri ([@bib9])* and highlighted these residues ([Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"}). It is noteworthy that most of the highlighted residues are surface-exposed, specifically on one half of the predicted CcoN4 structure, where they may engage in binding an unknown protein partner or specific lipids. In contrast, sites that have been described as points of interaction with CcoO and CcoP are mostly conserved, further supporting the notion that CcoN4 can interact with these subunits in Cco complexes.

Different CcoN subunits are required for competitive fitness in early or late colony development {#s2-3}
------------------------------------------------------------------------------------------------

To further test CcoN4's contribution to growth in biofilms, we performed competition assays in which ∆*N4* and other mutants were grown as mixed-strain biofilms with the wild type. In each of these assays, one strain was labeled with constitutively expressed YFP so that the strains could be distinguished during enumeration of colony-forming units (CFUs). Experiments were performed with the label on each strain to confirm that YFP expression did not affect fitness ([Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}). When competitive fitness was assessed after 3 days of colony growth ([Figure 3A](#fig3){ref-type="fig"}), ∆*N4* cells showed a disadvantage, with the wild type outcompeting *∆N4* by a factor of two. This was similar to the disadvantage observed for the *∆N1∆N2* mutant, further suggesting that the orphan subunit CcoN4 plays a significant role in biofilm metabolism. Remarkably, deletion of *ccoN4* in mutants already lacking *ccoN1* and *ccoN2* led to a drastic decrease in fitness, with the wild type outcompeting *∆N1∆N2∆N4* by a factor of 16. This disadvantage was comparable to that observed for the mutant lacking the full *cco* operons (*∆cco1cco2*), underscoring the importance of CcoN4-containing isoforms during biofilm growth.

![CcoN4 confers a competitive advantage in biofilms, particularly when O~2~ becomes limiting.\
(**A**) Relative fitness of various YFP-labeled *cco* mutants when co-cultured with WT in mixed-strain biofilms for 3 days. Error bars represent the standard deviation of biological triplicates. p-Values were calculated using unpaired, two-tailed t tests (\*\*p≤0.01; \*\*\*p≤0.001; \*\*\*\*p≤0.0001). (**B**) Time course showing relative fitness, over a period of 3 days, of various *cco* mutants when co-cultured with WT in mixed-strain biofilms. Results are shown for experiments in which the WT was co-cultured with various 'labeled' strains, that is, those that were engineered to constitutively express YFP. (See [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} for results from experiments in which the labeled WT was co-cultured with unlabeled mutants.) Error bars represent the standard deviation of biological triplicates. (**C**) Change in thickness over 3 days of development for colony biofilms of WT and ∆*phz* as assessed by thin sectioning and DIC microscopy. After the onset of wrinkling, thickness was determined for the base (i.e. the 'valley' between wrinkles). Error bars represent the standard deviation of biological triplicates. (**D**) O~2~ profiles of colonies at selected timepoints within the first 3 days of biofilm development. Gray point markers indicate measurements made in the agar directly below the colony. Error bars denote standard deviation of biological triplicates.](elife-30205-fig3){#fig3}

To further explore the temporal dynamics of N subunit utilization, we repeated the competition assay, but sampled each day over the course of 3 days ([Figure 3B](#fig3){ref-type="fig"}). The fitness disadvantage that we had found for strains lacking CcoN1 and CcoN2 was evident after only 1 day of growth and did not significantly change after that. In contrast, the ∆*N4*-specific decline in fitness did not occur before the second day. These data suggest that the contributions of the various N subunits to biofilm metabolism differ depending on developmental stage.

DIC imaging of thin sections from wild-type colonies reveals morphological variation over depth that may result from decreasing O~2~ availability ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). We have previously reported that 3-day-old PA14 colony biofilms are hypoxic at depth ([@bib17]) and that O~2~ availability is generally higher in thinner biofilms, such as those formed by the phenazine-null mutant ∆*phz*. We have proposed that the utilization of phenazines as electron acceptors in wild-type biofilms enables cellular survival in the hypoxic zone and promotes colony growth ([@bib46]). The relatively late-onset phenotype of the ∆*N4* mutant in the competition assay suggested to us that CcoN4 may play a role in survival during formation of the hypoxic colony subzone and that this zone could arise at a point between 1 and 2 days of colony growth. We measured O~2~ concentrations in wild-type and ∆*phz* biofilms at specific time points over development, and found that O~2~ declined similarly with depth in both strains ([Figure 3D](#fig3){ref-type="fig"}). The rate of increase in height of ∆*phz* tapered off when a hypoxic zone began to form, consistent with the notion that the base does not increase in thickness when electron acceptors (O~2~ or phenazines) are not available. Although we cannot pinpoint the exact depth at which the O~2~ microsensor leaves the colony base and enters the underlying agar, we can estimate these values based on colony thickness measurements ([Figure 3C](#fig3){ref-type="fig"}). When we measured the thickness of wild-type and ∆*phz* biofilms over 3 days of incubation, we found that the values began to diverge between 30 and 48 hr of growth, after the colonies reached \~70 µm in height, which coincides with the depth at which O~2~ becomes undetectable. ∆*phz* colonies reached a maximum thickness of \~80 µm, while wild-type colonies continued to grow to \~150 µm ([Figure 3C](#fig3){ref-type="fig"}). In this context, it is interesting to note that the point of divergence for the increase in wild-type and ∆*phz* colony thickness---between 30 and 48 hr---corresponds to the point at which CcoN4 becomes important for cell viability in our mixed-strain colony growth experiments ([Figure 3B](#fig3){ref-type="fig"}). We hypothesize that this threshold thickness leads to a level of O~2~ limitation that is physiologically relevant for the roles of phenazines and CcoN4 in biofilm metabolism.

*cco* genes show differential expression across biofilm subzones {#s2-4}
----------------------------------------------------------------

*P. aeruginosa*'s five canonical terminal oxidases are optimized to function under and in response to distinct environmental conditions, including various levels of O~2~ availability ([@bib3]; [@bib34]; [@bib1]; [@bib10]). Furthermore, recent studies, along with our results, suggest that even within the Cco terminal oxidase complexes, the various N subunits may perform different functions ([@bib29]). We sought to determine whether differential regulation of *cco* genes could lead to uneven expression across biofilm subzones. To test this, we engineered reporter strains in which GFP expression is regulated by the *cco1*, *cco2*, or *ccoN4Q4* promoters. Biofilms of these strains were grown for 3 days, thin-sectioned, and imaged by fluorescence microscopy. Representative results are shown in the left panel of [Figure 4](#fig4){ref-type="fig"}. The right panel of [Figure 4](#fig4){ref-type="fig"} contains plotted GFP signal intensity and O~2~ concentration measurements over depth for PA14 wild-type colonies. *cco1* and *ccoN4* expression patterns indicate that the Cco1 oxidase and the CcoN4 subunit are produced throughout the biofilm ([Figure 4](#fig4){ref-type="fig"}). *cco2* expression, on the other hand, is relatively low in the top portion of the biofilm and shows a sharp induction starting at a depth of \~45 µm. This observation is consistent with previous studies showing that *cco2* expression is regulated by Anr, a global transcription factor that controls gene expression in response to a shift from oxic to anoxic conditions ([@bib10]; [@bib34]; [@bib52]).

![*cco* genes are differentially expressed over biofilm depth.\
Left: Representative images of thin sections prepared from WT biofilms grown for 3 days. Each biofilm is expressing a translational GFP reporter under the control of the *cco1*, *cco2*, or *ccoN4Q4* promoter. Reporter fluorescence is shown in green and overlain on respective DIC images. Right: Fluorescence values corresponding to images on the left. Fluorescence values for a strain containing the *gfp* gene without a promoter (the empty MCS control) have been subtracted from each respective plot. O~2~ concentration over depth (open circles) from 3-day-old WT biofilms is also shown. Error bars represent the standard deviation of biological triplicates and are not shown in cases where they would be obscured by the point markers. y-axis in the right panel provides a scale bar for the left panel. Reporter fluorescence images and values are representative of 4 biological replicates.](elife-30205-fig4){#fig4}

Although previous studies have evaluated expression as a function of growth phase in shaken liquid cultures for *cco1* and *cco2*, this property has not been examined for *ccoN4Q4*. We monitored the fluorescence of our engineered *cco* gene reporter strains during growth under this condition in a nutrient-rich medium. As expected based on the known constitutive expression of *cco1* and Anr-dependence of *cco2* induction, we saw *cco1*-associated fluorescence increase before that associated with *cco2*. Induction of *ccoN4Q4* occurred after that of *cco1* and *cco2* ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), consistent with microarray data showing that this locus is strongly induced by O~2~ limitation ([@bib1]). However, our observation that *ccoN4Q4* is expressed in the aerobic zone, where *cco2* is not expressed, in biofilms ([Figure 4](#fig4){ref-type="fig"}) suggests that an Anr-independent mechanism functions to induce this operon during multicellular growth.

Our results indicate that different Cco isoforms may function in specific biofilm subzones, but that CcoN4-containing isoforms could potentially form throughout the biofilm. These data, together with our observation that ∆*N4* biofilms exhibit a fitness disadvantage from day 2 ([Figure 3B](#fig3){ref-type="fig"}), led us to more closely examine the development and chemical characteristics of the biofilm over depth.

Microelectrode-based redox profiling reveals differential phenazine reduction activity in wild-type and *cco* mutant biofilms {#s2-5}
-----------------------------------------------------------------------------------------------------------------------------

The results shown in [Figure 2B](#fig2){ref-type="fig"} implicate CcoN4-containing isoforms in the reduction of TTC, a small molecule that interacts with the respiratory chain ([@bib54]). Similar activities have been demonstrated for phenazines, including the synthetic compound phenazine methosulfate (PMS) ([@bib43]) and those produced naturally by *P. aeruginosa* ([@bib4]). Given that CcoN4 and phenazines function to influence morphogenesis at similar stages of biofilm growth ([Figures 2A](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}), we wondered whether the role of CcoN4 in biofilm development was linked to phenazine metabolism. We used a Unisense platinum microelectrode with a 20--30 µm tip to measure the extracellular redox potential in biofilms as a function of depth. This electrode measures the inclination of the sample to donate or accept electrons relative to a Ag/AgCl reference electrode. We found that wild-type colonies showed a decrease in redox potential over depth, indicating an increased ratio of reduced to oxidized phenazines, while the redox potential of ∆*phz* colonies remained unchanged ([Figure 5A](#fig5){ref-type="fig"}). To confirm that phenazines are the primary determinant of the measured redox potential in the wild type, we grew ∆*phz* colonies on medium containing PMS (which resembles the natural phenazines that regulate *P. aeruginosa* colony morphogenesis \[[@bib57]\]) and found that these colonies yielded redox profiles similar to those of the wild type ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Therefore, although the microelectrode we employed is capable of interacting with many redox-active substrates, we found that its signal was primarily determined by phenazines in our system. In addition, while wild-type colonies showed rapid decreases in O~2~ availability starting at the surface, the strongest decrease in redox potential was detected after \~50 µm ([Figure 5A](#fig5){ref-type="fig"}). These results suggest that the bacteria residing in the biofilm differentially utilize O~2~ and phenazines depending on their position and that O~2~ is the preferred electron acceptor.

![Characterization of chemical gradients and matrix distribution in PA14 WT and mutant colony biofilms.\
(**A**) Left: Change in O~2~ concentration (blue) and redox potential (orange) with depth for WT and ∆*phz* biofilms grown for two days. WT biofilms are \~150 µm thick while ∆*phz* biofilms are \~80 µm thick. For O~2~ profiles, error bars represent the standard deviation of biological triplicates. For redox profiles, data are representative of at least 5 biological replicates. Right: model depicting the distribution of O~2~ and reduced vs. oxidized phenazines in biofilms. (**B**) Top: Change in redox potential with depth for WT and various mutant biofilms grown for 2 days. Data are representative of at least 5 biological replicates. Bottom: Thickness of 3-day-old colony biofilms of the indicated strains. Bars represent the average of the plotted data points (each point representing a biological replicate, n ≥ 4), and error bars represent the standard deviation. p-Values were calculated using unpaired, two-tailed t tests comparing each mutant to WT (n.s., not significant; \*\*p≤0.01; \*\*\*\*p≤0.0001). (**C**) Left: Representative thin sections of WT and *cco* mutant biofilms, stained with lectin and imaged by fluorescence microscopy. Biofilms were grown for 2 days before sampling. Right: Relative quantification of lectin stain signal intensity. Coloration of strain names in the left panel provides a key for the plotted data, and the y-axis in the right panel provides a scale bar for the left panel. Lectin-staining images and values are representative of 4 biological replicates.](elife-30205-fig5){#fig5}

We hypothesized that one or more of the CcoN subunits encoded by the PA14 genome is required for phenazine reduction and tested this by measuring the redox potential over depth for a series of *cco* mutants ([Figure 5B](#fig5){ref-type="fig"}, top). We saw very little reduction of phenazines in the ∆*cco1cco2* colony, suggesting that *cbb*~3~-type oxidases are required for this activity. In contrast, the mutant lacking the catalytic subunits of Cco1 and Cco2, ∆*N1*∆*N2*, showed a redox profile similar to the wild type, indicating that isoforms containing one or both of the orphan CcoN subunits could support phenazine reduction activity. Indeed, although redox profiles obtained for the ∆*N1*∆*N2* and ∆*N4* mutants were similar to those obtained for the wild type, the redox profile of the ∆*N1*∆*N2*∆*N4* mutant recapitulated that of ∆*cco1cco2.* These results indicate redundancy in the roles of some of the CcoN subunits. Consistent with this, ∆*N1∆N4* showed an intermediate defect in phenazine reduction. We note that the triple mutant ∆*cox*∆*cyo*∆*cio* showed a wild-type-like redox profile, indicating that the *cbb*~3~-type terminal oxidases are sufficient for normal phenazine reduction ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Extraction and measurement of phenazines released from wild-type and *cco* mutant biofilms showed that variations in redox profiles could not be attributed to differences in phenazine production ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}).

Our group has previously shown that a ∆*phz* mutant compensates for its lack of phenazines by forming thinner colonies, thus limiting the development of the hypoxic subzone seen in the wild type ([@bib17]). We therefore hypothesized that mutants unable to reduce phenazines would likewise result in thinner colonies. Indeed, we observed that the *cco* mutants that lacked phenazine reduction profiles in the top panel of [Figure 5B](#fig5){ref-type="fig"} produced biofilms that were significantly thinner than wild-type and comparable to that of the ∆*phz* mutant ([Figure 5B](#fig5){ref-type="fig"}, bottom).

Our group has also reported that reduction of nitrate, an alternate electron acceptor for *P. aeruginosa* ([@bib67]), can serve as an additional redox-balancing strategy for cells in biofilms ([@bib17]). Colony wrinkling is stimulated by a reduced cellular redox state; thus, provision of nitrate in the growth medium inhibits colony feature formation. We hypothesized that nitrate reduction could compensate for defects in O~2~ and phenazine reduction and inhibit colony wrinkling in the *cco* mutants that are the focus of this study. To test this, we grew strains on medium containing 10 or 40 mM potassium nitrate. We found that 10 mM nitrate was sufficient to inhibit wrinkling for up to 4 days of incubation in the wild type, ∆*N4*, and ∆*N1*∆*N4*, but that ∆*phz* and ∆*N1*∆*N2*∆*N4* had initiated wrinkling at this point ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). When we grew these strains on medium containing 40 mM nitrate, we saw increased inhibition of wrinkling such that the wild type, ∆*phz*, ∆*N4*, and ∆*N1*∆*N4* remained completely smooth at 4 days of incubation. Although ∆*N1*∆*N2*∆*N4* had shown some feature formation after 4 days on this medium, it was diminished relative to the same point on 10 mM nitrate. These results suggest that O~2~ reduction, phenazine reduction, and nitrate reduction can operate in synchrony to oxidize the redox states of cells in biofilms and that provision of nitrate can compensate for defects in O~2~ and phenazine reduction to enable maintenance of redox homeostasis.

Wild-type and *cco* mutant colony biofilms show increased matrix production at comparable depths {#s2-6}
------------------------------------------------------------------------------------------------

We have recently demonstrated that extracellular matrix production, a hallmark of biofilm formation, is regulated by redox state in PA14 colony biofilms. Increased matrix production correlates with the accumulation of reducing power (as indicated by higher cellular NADH/NAD^+^ ratios) due to electron acceptor limitation and is visible in the hypoxic region of ∆*phz* colonies ([@bib17]; [@bib45]). The morphologies of our *cco* mutants ([Figure 2A](#fig2){ref-type="fig"}) suggest that matrix production can also be induced by respiratory chain dysfunction, which may be linked to defects in phenazine utilization ([Figure 5B](#fig5){ref-type="fig"}). To further examine the relationships between Cco isoforms and redox imbalance in biofilms, we prepared thin sections from 2-day-old colonies and stained with fluorescein-labeled lectin, which binds preferentially to the Pel polysaccharide component of the matrix ([@bib32]). Consistent with their similar gross morphologies, the wild-type and *∆N1∆N2* biofilms showed similar patterns of staining, with a faint band of higher intensity at a depth of \~40 µm ([Figure 5C](#fig5){ref-type="fig"}). ∆*N4* also showed a similar pattern, with a slightly higher intensity of staining in this band. *∆N1∆N2∆N4* and *∆cco1cco2* showed more staining throughout each sample, with wider bands of greater intensity at the \~40 µm point. These data suggest that deletion of the Cco complexes leads to a more reduced cellular redox state, which induces production of more matrix, and that CcoN4 contributes significantly to maintaining redox homeostasis when O~2~ is limiting.

CcoN4 contributes to *P. aeruginosa* virulence in a *C. elegans* slow killing model {#s2-7}
-----------------------------------------------------------------------------------

We have previously shown that a mutant defective in biofilm-specific phenazine production, which also shows altered colony morphology ([@bib19]; [@bib17]), exhibits decreased virulence ([@bib53]). We and others have suggested that one way in which phenazines could contribute to virulence is by acting as electron acceptors to balance the intracellular redox state in the hypoxic conditions that are encountered during infection ([@bib50]; [@bib44]; [@bib17]). Because CcoN4 is required for wild-type biofilm architecture and respiration ([Figures 2A, C](#fig2){ref-type="fig"} and [5C](#fig5){ref-type="fig"}), we hypothesized that it could also contribute to virulence. To test this, we conducted virulence assays using the nematode *Caenorhabditis elegans* as a host. It has been shown that *P. aeruginosa* is pathogenic to *C. elegans* and that the slow killing assay mimics an infection-like killing of *C. elegans* by the bacterium ([@bib62]). While *∆N1∆N2* killed with wild-type-like kinetics, *∆N1∆N2∆N4* and *∆cco1cco2* showed comparably-impaired killing relative to wild-type PA14 ([Figure 6](#fig6){ref-type="fig"}).

![CcoN4-containing isoform(s) make unique contributions to PA14 virulence.\
Slow-killing kinetics of WT, *gacA*, and various *cco* mutant strains in the nematode *Caenorhabditis elegans*. Nearly 100% of the *C. elegans* population exposed to WT PA14 is killed after 4 days of exposure to the bacterium, while a mutant lacking GacA, a regulator that controls expression of virulence genes in *P. aeruginosa*, shows decreased killing, with \~50% of worms alive 4 days post-exposure. (**A**) *∆N1∆N2∆N4* and *∆cco1cco2* show comparably attenuated pathogenicity relative to WT. Error bars represent the standard deviation of at least 6 biological replicates. At 2.25 days post-exposure, significantly less *C. elegans* were killed by ∆*N1*∆*N2*∆*N4* than by WT (unpaired two-tailed t test; p=0.0022). (**B**) *∆N1∆N2* displays only slightly reduced pathogenicity when compared to WT. At 2.25 days post-exposure, significantly more *C. elegans* were killed by ∆*N1*∆*N2* than by ∆*N1*∆*N2*∆*N4* (unpaired two-tailed t test; p=0.003). Error bars represent the standard deviation of at least 4 biological replicates, each with a starting sample size of 30--35 worms per replicate.](elife-30205-fig6){#fig6}

Discussion {#s3}
==========

Biofilm formation contributes to *P. aeruginosa* pathogenicity and persistence during different types of infections, including the chronic lung colonizations seen in individuals with cystic fibrosis ([@bib63]; [@bib55]). The conditions found within biofilm microenvironments are distinct from those in well-mixed liquid cultures with respect to availability of electron donors and acceptors. We have previously described the roles of phenazines, electron-shuttling antibiotics produced by *P. aeruginosa*, in biofilm-specific metabolism. In this study, we focused on *P. aeruginosa*'s large complement of genes encoding *cbb*~3~-type cytochrome oxidase subunits and set out to test their contributions to metabolic electron flow in biofilms.

The *P. aeruginosa* genome contains four different homologs of *ccoN*, encoding the catalytic subunit of *cbb*~3~-type oxidase. Only two of these (*ccoN1* and *ccoN2*) are co-transcribed with a *ccoO* homolog, encoding the other critical component of an active *cbb*~3~-type oxidase ([Figure 1B](#fig1){ref-type="fig"}). However, genetic studies have demonstrated that all four versions of CcoN can form functional complexes when expressed with either of the two CcoO homologs ([@bib29]). In well-mixed liquid cultures, mutants lacking the 'orphan' subunits did not show growth defects ([Figure 2C](#fig2){ref-type="fig"}) ([@bib29]). We were therefore surprised to find that the ∆*N4* mutant showed a unique morphotype in a colony biofilm assay ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). We have applied this assay extensively in our studies of the mechanisms underlying cellular redox balancing and sensing and noted that the phenotype of ∆*N4* was similar to that of mutants with defects in electron shuttling and redox signaling ([@bib17]; [@bib45]).

We characterized the effects of a ∆*N4* mutation on biofilm physiology through a series of assays. In well-mixed liquid cultures, ∆*cco1cco2* showed a growth phenotype similar to that of ∆*N1*∆*N2*. While Hirai et al. have shown that wild-type *P. aeruginosa* cultures grown planktonically do form Cco heterocomplexes containing CcoN4, our observations suggest that such complexes do not contribute significantly to growth under these conditions. Consistent with this, deleting *ccoN4* in the ∆*N1*∆*N2* background had no effect on planktonic growth ([Figure 2C](#fig2){ref-type="fig"}). However, in biofilm-based experiments, we found that deleting *N4* alone was sufficient to cause an altered morphology phenotype ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), and that deleting *N4* in either a ∆*N1* or a ∆*N1*∆*N2* background profoundly affected biofilm physiology. These experiments included quantification of respiratory activity in colonies, in which deletion of CcoN4 led to a significant decrease ([Figure 2B](#fig2){ref-type="fig"}); biofilm co-culturing, in which CcoN4 was required for competitive fitness ([Figure 3A and B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}); redox profiling, which showed that CcoN4 can contribute to phenazine reduction ([Figure 5B](#fig5){ref-type="fig"}, top); colony thickness measurements, which showed that CcoN4 is required for the formation of the hypoxic and anoxic zones ([Figure 5B](#fig5){ref-type="fig"}, bottom); and matrix profiling, which showed that CcoN4 contributes to the repression of Pel polysaccharide production ([Figure 5C](#fig5){ref-type="fig"}). The overlap in zones of expression between *cco1*, *cco2*, and *ccoN4Q4* seen in colony thin sections ([Figure 4](#fig4){ref-type="fig"}) implies that CcoN4 can form heterocomplexes with Cco1 and Cco2 subunits that span the depth of the colony and function to influence the physiology of *P. aeruginosa* biofilms in these ways.

The mutant phenotypes and gene expression profiles reported in this study suggest roles for CcoN4 in O~2~ and phenazine reduction specifically in the biofilm context, and allow us to draw conclusions about the roles of other CcoN subunits. The expression of *ccoN4Q4* throughout the biofilm depth suggests that CcoN4-containing isoforms could contribute to cytochrome *c* oxidation in both oxic and hypoxic zones ([Figure 4](#fig4){ref-type="fig"}). This constitutes a deviation from the previously published observation that these genes are specifically induced in hypoxic liquid cultures when compared to well-aerated ones ([@bib1]). Therefore, the *ccoN4Q4* expression we observed in the relatively oxic, upper portion of the colony may be specific to biofilms.

∆*N4* displayed a colony morphology indicative of redox stress and had a fitness disadvantage compared to the wild type ([Figures 2A](#fig2){ref-type="fig"} and [3A,B](#fig3){ref-type="fig"}, [Figure 5B](#fig5){ref-type="fig"}, bottom, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). However, because it did not show a defect in phenazine reduction ([Figure 5B](#fig5){ref-type="fig"}, top), we attribute its colony morphology and impaired fitness phenotypes to its proposed role in O~2~ reduction ([@bib29]). Similarly, ∆*N1*∆*N2* showed reduced fitness compared to the wild type ([Figure 3A and B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) while showing phenazine reduction comparable to that of the wild type ([Figure 5B](#fig5){ref-type="fig"}), implying that one or both of these subunits contribute to O~2~ reduction in biofilms. When CcoN4 was deleted in conjunction with CcoN1 and CcoN2, however, the resulting strain showed a severe phenazine reduction defect, a phenotype recapitulated by deleting both *cco* operons ([Figure 5B](#fig5){ref-type="fig"}). Thus, our observations suggest a role for the *cbb*~3~-type oxidases in phenazine reduction in addition to their established roles in O~2~ reduction, thereby expanding our understanding of their overall contributions *P. aeruginosa*'s physiology and viability.

The results described here can inform our model of how cells survive under distinct conditions in the microenvironments within biofilms. Previous work has shown that pyruvate fermentation can support survival of *P. aeruginosa* under anoxic conditions ([@bib23]) and that phenazines facilitate this process ([@bib27]). Additional research suggests that phenazine reduction is catalyzed adventitiously by *P. aeruginosa* flavoproteins and dehydrogenases ([@bib28]). Our observation that *cbb*~3~-type cytochrome oxidases, particularly those containing the CcoN1 or CcoN4 subunits, were required for phenazine reduction in hypoxic biofilm subzones ([Figure 5B](#fig5){ref-type="fig"}) further implicates the electron transport chain in utilization of these compounds. It is also interesting in light of the historical roles of phenazines acting as mediators in biochemical studies of the cytochrome *bc*~1~ complex and cytochrome oxidases ([@bib37]; [@bib4]; [@bib13]). Based on this earlier work, we can speculate that different CcoN subunits may indirectly influence phenazine reduction, which could occur at the cytochrome *c* binding site of the CcoO subunit or elsewhere in the electron transport chain, through effects these CcoN subunits have on the overall function or stability of respiratory complexes. Ultimately, various mechanisms of phenazine reduction and phenazine-related metabolisms may be relevant at different biofilm depths or depending on electron donor availability. Our results suggest that, in the colony biofilm system, enzyme complexes traditionally considered to be specific to O~2~ reduction may contribute to anaerobic survival.

Because biofilm formation is often associated with colonization of and persistence in hosts, we tested whether CcoN4 contributes to *P. aeruginosa* pathogenicity in *C. elegans*. Similar to our observations in biofilm assays, we found that the ∆*cco1cco2* mutant displayed a more severe phenotype than the ∆*N1*∆*N2* mutant, suggesting that an orphan subunit can substitute for those encoded by the *cco1* and *cco2* operons. We also found that deleting *ccoN4* in ∆*N1*∆*N2* led to a ∆*cco1cco2*-like phenotype, suggesting that CcoN4 is the subunit that can play this role ([Figure 6](#fig6){ref-type="fig"}). In host microenvironments where O~2~ is available, CcoN4-containing isoforms could contribute to its reduction. Additionally, in hypoxic zones, CcoN4-containing isoforms could facilitate the reduction of phenazines, enabling cellular redox balancing. Both these functions would contribute to persistence of the bacterium within the host. The contributions of the *cbb*~3~-type oxidases to *P. aeruginosa* pathogenicity raise the possibility that compounds interfering with Cco enzyme function could be effective therapies for these infections. Such drugs would be attractive candidates due to their specificity for bacterial respiratory chains and, as such, would not affect the host's endogenous respiratory enzymes.

Our discovery that an orphan *cbb*~3~-type oxidase subunit contributes to growth in biofilms further expands the scope of *P. aeruginosa*'s remarkable respiratory flexibility. Beyond modularity at the level of the terminal enzyme complex (e.g. utilization of an *aa*~3~- vs. a *cbb*~3~-type oxidase), the activity of *P. aeruginosa*'s respiratory chain is further influenced by substitution of orphan *cbb*~3~-type catalytic subunits for native ones. Utilization of CcoN4-containing isoforms promotes phenazine reduction activity and may influence aerobic respiration in *P. aeruginosa* biofilms. For the exceptional species that contain orphan *cbb*~3~-type catalytic subunits, this fine level of control could be particularly advantageous during growth and survival in environments covering a wide range of electron acceptor availability ([@bib12]).

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\        Designation                    Source or reference       Identifiers   Additional information
  or resource                                                                                           
  ------------------------------ ------------------------------ ------------------------- ------------- ------------------------------------------------------
  strain, strain background\     wild type (WT)                 PMID: 7604262                           
  (UCBPP-PA14\                                                                                          
  *Pseudomonas aeruginosa*)                                                                             

  strain, strain background\     ∆*phz*                         PMID: 16879411                          LD24
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*; *∆N1*                this study                              LD1784
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN2; ∆N2*                  this study                              LD1614
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN3; ∆N3*                  this study                              LD1620
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN4; ∆N4*                  this study                              LD2833
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN2*; ∆*N1*∆*N2*   this study                              LD1888
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN4; ∆N1∆N4*       this study                              LD1951
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN2*∆*ccoN4; ∆N2∆N4*       this study                              LD1692
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN3*∆*ccoN4; ∆N3∆N4*       this study                              LD1649
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN2*∆*ccoN3;*\     this study                              LD1977
  (UCBPP-PA14 *P. aeruginosa*)   *∆N1∆N2*∆*N3*                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN2*∆*ccoN4;*\     this study                              LD1976
  (UCBPP-PA14 *P. aeruginosa*)   *∆N1∆N2∆N4*                                                            

  strain, strain background\     ∆*ccoN1*∆*ccoN2*∆*ccoN4*\      this study                              LD2020
  (UCBPP-PA14 *P. aeruginosa*)   ∆*ccoN3; ∆N1∆N2∆N4*∆*N3*                                               

  strain, strain background\     ∆*cco1cco2*                    this study                              LD1933
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*cox*∆*cyo*∆*cio*             this study                              LD2587
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*hcn*                         this study                              LD2827
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*phz*∆*hcn*                   this study                              LD2828
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN4*∆*hcn; ∆N4∆hcn*        this study                              LD2829
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN2*∆*hcn;*\       this study                              LD2830
  (UCBPP-PA14 *P. aeruginosa*)   *∆N1∆N2∆hcn*                                                           

  strain, strain background\     ∆*ccoN1*∆*ccoN2*∆*ccoN4*\      this study                              LD2831
  (UCBPP-PA14 *P. aeruginosa*)   ∆*hcn; ∆N1∆N2∆N4*∆*hcn*                                                

  strain, strain background\     ∆*cco1cco2*∆*hcn*              this study                              LD2832
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     *gacA::Tn*                     PMID: 16477005                          LD1560
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN4*::*ccoN4; ∆N4::N4*     this study                              LD1867
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN2*∆*ccoN4::*\    this study                              LD2576
  (UCBPP-PA14 *P. aeruginosa*)   *ccoN4; ∆N1∆N2∆N4::N4*                                                 

  strain, strain background\     MCS-*gfp*                      this study                              LD2820
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     *Pcco1-gfp*; *cco1Pr-gfp*      this study                              LD2784
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     *Pcco2-gfp*; *cco2Pr-gfp*      this study                              LD2786
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     *PccoN4-gfp; ccoN4Pr-gfp*      this study                              LD2788
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     PA14-*yfp*                     this study                              LD2780
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN2-yfp*;\         this study                              LD2013
  (UCBPP-PA14 *P. aeruginosa*)   ∆*N1*∆*N2-yfp*                                                         

  strain, strain background\     ∆*ccoN4-yfp*; ∆*N4-yfp*        this study                              LD2834
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     ∆*ccoN1*∆*ccoN2*∆*cco*\        this study                              LD2136
  (UCBPP-PA14 *P. aeruginosa*)   *N4-yfp; ∆N1∆N2*∆*N4-yfp*                                              

  strain, strain background\     ∆*cco1cco2-yfp*                this study                              LD2012
  (UCBPP-PA14 *P. aeruginosa*)                                                                          

  strain, strain background\     UQ950                          other                                   From D. Lies, Caltech; LD44
  (*Escherichia coli*)                                                                                  

  strain, strain background\     BW29427                        other                                   From W. Metcalf, University of Illinois; LD661
  (*E. coli*)                                                                                           

  strain, strain background\     β2155                          PMID: 8990308                           LD69
  (*E. coli*)                                                                                           

  strain, strain background\     S17-1                          doi:10.1038/nbt1183-784                 LD2901
  (*E. coli*)                                                                                           

  strain, strain background\     InvSc1                         Invitrogen                              LD676
  (*Saccharomyces cerevisiae*)                                                                          

  recombinant DNA reagent        pMQ30 (plasmid)                PMID: 16820502                          For generation of deletion constructs listed above;\
                                                                                                        further information can be found in the\
                                                                                                        Materials and Methods section.

  recombinant DNA reagent        pAKN69 (plasmid)               PMID: 15186351                          For generation of strains constitutively\
                                                                                                        expression *eyfp*; further information can be\
                                                                                                        found in the Materials and Methods section.

  recombinant DNA reagent        pLD2722 (plasmid)              this study                              For generation of *gfp* reporter constructs;\
                                                                                                        further information can be found in the\
                                                                                                        Materials and Methods section.

  recombinant DNA reagent        pFLP2 (plasmid)                PMID: 9661666                           For generation of *gfp* reporter constructs;\
                                                                                                        further information can be found in the\
                                                                                                        Materials and Methods section.

  software, algorithm            EggNOG Database                PMID: 26582926                          <http://eggnogdb.embl.de/#/app/home>

  software, algorithm            SensorTrace Profiling          Unisense                                For data acquisition for redox and oxygen\
                                                                                                        microprofiling; further information can be\
                                                                                                        found in the Materials and Methods section.

  other                          Agar                           Teknova                                 For colony morphology assays;\
                                                                                                        further information can be found in the\
                                                                                                        Materials and Methods section.

  other                          Lectin                         Vector Laboratories                     For visualization of matrix;\
                                                                                                        further information can be found\
                                                                                                        in the Materials and Methods section.
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

Bacterial strains and growth conditions {#s4-1}
---------------------------------------

*P. aeruginosa* strain UCBPP-PA14 ([@bib51]) was routinely grown in lysogeny broth (LB; 1% tryptone, 1% NaCl, 0.5% yeast extract) ([@bib5]) at 37˚C with shaking at 250 rpm unless otherwise indicated. Overnight cultures were grown for 12--16 hr. For genetic manipulation, strains were typically grown on LB solidified with 1.5% agar. Strains used in this study are listed in [Table 1](#table1){ref-type="table"}. In general, liquid precultures served as inocula for experiments. Overnight precultures for biological replicates were started from separate clonal source colonies on streaked agar plates. For technical replicates, a single preculture served as the source inoculum for subcultures.

10.7554/eLife.30205.016

###### Strains used in this study.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain                               Number   Description                                                                                                                                                                                                          Source
  ------------------------------------ -------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------
  *Pseudomonas aeruginosa* strains                                                                                                                                                                                                                                   

  UCBPP-PA14                                    Clinical isolate UCBPP-PA14.                                                                                                                                                                                         [@bib51]

  PA14 ∆*phz*                          LD24     PA14 with deletions in *phzA1-G1* and *phzA2-G2*\                                                                                                                                                                    [@bib18]
                                                operons.                                                                                                                                                                                                             

  PA14 ∆*ccoN1*                        LD1784   PA14 with deletion in PA14_44370.                                                                                                                                                                                    this study

  PA14 ∆*ccoN2*                        LD1614   PA14 with deletion in PA14_44340.                                                                                                                                                                                    this study

  PA14 ∆*ccoN3*                        LD1620   PA14 with deletion in PA14_40510.                                                                                                                                                                                    this study

  PA14 ∆*ccoN4*                        LD2833   PA14 with deletion in PA14_10500.                                                                                                                                                                                    this study

  PA14 ∆*ccoN1*\                       LD1888   PA14 with deletions in PA14_44370 and PA14_44340. Made by mating pLD1610 into LD1784.                                                                                                                                this study
  ∆*ccoN2*                                                                                                                                                                                                                                                           

  PA14 ∆*ccoN1*\                       LD1951   PA14 with deletions in PA14_44370 and PA14_10500. Made by mating pLD1264 into LD1784.                                                                                                                                this study
  ∆*ccoN4*                                                                                                                                                                                                                                                           

  PA14 ∆*ccoN2*\                       LD1692   PA14 with deletions in PA14_44340 and PA14_10500. Made by mating pLD1264 into LD1614.                                                                                                                                this study
  ∆*ccoN4*                                                                                                                                                                                                                                                           

  PA14 ∆*ccoN3*\                       LD1649   PA14 with deletions in PA14_40510 and PA14_10500. Made by mating pLD1264 into LD1620.                                                                                                                                this study
  ∆*ccoN4*                                                                                                                                                                                                                                                           

  PA14 ∆*ccoN1*\                       LD1977   PA14 with deletions in PA14_443470, PA14_44340, and PA14_40510. Made by mating pLD1616 into LD1888.                                                                                                                  this study
  ∆*ccoN2* ∆*ccoN3*                                                                                                                                                                                                                                                  

  PA14 ∆*ccoN1*\                       LD1976   PA14 with deletions in PA14_443470, PA14_44340, and PA14_10500. Made by mating pLD1264 into LD1888.                                                                                                                  this study
  ∆*ccoN2* ∆*ccoN4*                                                                                                                                                                                                                                                  

  PA14 ∆*ccoN1*\                       LD2020   PA14 with deletions in PA14_443470, PA14_44340, PA14_10500, and PA14_40510. Made by mating pLD1264 into LD1977.                                                                                                      this study
  ∆*ccoN2* ∆*ccoN4*\                                                                                                                                                                                                                                                 
  ∆*ccoN3*                                                                                                                                                                                                                                                           

  PA14 ∆*cco1cco2*                     LD1933   PA14 with both *cco* operons (PA14_44340-PA14_44400) deleted simultaneously.                                                                                                                                         this study

  PA14 ∆*cox* ∆*cyo* ∆*cio*            LD2587   PA14 with deletions in PA14_01290--01320 (*cox*/*aa*3 operon), PA14_47150--47210 (*cyo*/*bo*3 operon), and PA14_13030--13040 (*cio* operon). Made by mating pLD1966, pLD1967, and pLD2044, in that order, to PA14.   this study

  PA14 ∆*hcn*                          LD2827   PA14 with deletion in *hcnABC* operon (PA14_36310--36330).                                                                                                                                                           this study

  PA14 ∆*phz* ∆*hcn*                   LD2828   PA14 with deletions in *phzA1-G1, phzA2-G2,* and *hcnABC* operons. Made by mating pLD2791 into LD24.                                                                                                                 this study

  PA14 ∆*ccoN4* ∆*hcn*                 LD2829   PA14 with deletions in PA14_10500 and *hcnABC* operon. Made by mating pLD2791 into LD2833.                                                                                                                           this study

  PA14 ∆*ccoN1*\                       LD2830   PA14 with deletions in PA14_44370, PA14_44340, and *hcnABC* operon. Made by mating pLD2791 into LD1888.                                                                                                              this study
  ∆*ccoN2* ∆*hcn*                                                                                                                                                                                                                                                    

  PA14 ∆*ccoN1*\                       LD2831   PA14 with deletions in PA14_44370, PA14_44340, PA14_10500 and *hcnABC* operon. Made by mating pLD2791 into LD1976.                                                                                                   this study
  ∆*ccoN2* ∆*ccoN4* ∆*hcn*                                                                                                                                                                                                                                           

  *Pseudomonas aeruginosa* strains                                                                                                                                                                                                                                   

  PA14 ∆*cco1cco2*\                    LD2832   PA14 with deletions in *cco1*, *cco2*, and *hcnABC* operons. Made by mating pLD2791 into LD1933.                                                                                                                     this study
  ∆*hcn*                                                                                                                                                                                                                                                             

  PA14 *gacA*::*Tn*                    LD1560   MAR2xT7 transposon insertion into PA14_30650.                                                                                                                                                                        [@bib41]

  PA14 ∆*ccoN4*::*ccoN4*               LD1867   PA14 ∆*ccoN4* strain with wild-type *ccoN4* complemented back into the site of deletion. Made by mating pLD1853 into LD2833.                                                                                         this study

  PA14 ∆*ccoN1*\                       LD2576   PA14 ∆*ccoN1* ∆*ccoN2* ∆*ccoN4* strain with wild-type *ccoN4* complemented back into the site of deletion. Made by mating pLD1853 into LD1976.                                                                       this study
  ∆*ccoN2*\                                                                                                                                                                                                                                                          
  ∆*ccoN4*::*ccoN4*                                                                                                                                                                                                                                                  

  PA14 MCS-gfp                         LD2820   PA14 without a promoter driving *gfp* expression.                                                                                                                                                                    this study

  PA14 P*cco-1*-gfp                    LD2784   PA14 with promoter of *cco1* operon driving *gfp* expression.                                                                                                                                                        this study

  PA14 P*cco-2*-gfp                    LD2786   PA14 with promoter of *cco2* operon driving *gfp* expression.                                                                                                                                                        this study

  PA14 P*ccoN4*-gfp                    LD2788   PA14 with promoter of *ccoN4Q4* operon driving *gfp* expression.                                                                                                                                                     this study

  PA14-yfp                             LD2780   WT PA14 constitutively expressing *eyfp*.                                                                                                                                                                            this study

  PA14 ∆*ccoN1*\                       LD2013   PA14 ∆*ccoN1* ∆*ccoN2* constitutively expressing *eyfp*. Made by mating pAKN69 into LD1888.                                                                                                                          this study
  ∆*ccoN2*-yfp                                                                                                                                                                                                                                                       

  PA14 ∆*ccoN4*-yfp                    LD2834   PA14 ∆*ccoN4* constitutively expressing *eyfp*. Made by mating pAKN69 into LD2833.                                                                                                                                   this study

  PA14 ∆*ccoN1*\                       LD2136   PA14 ∆*ccoN1* ∆*ccoN2* ∆*ccoN4* constitutively expressing *eyfp*. Made by mating pAKN69 into LD1976.                                                                                                                 this study
  ∆*ccoN2* ∆*ccoN4*-yfp                                                                                                                                                                                                                                              

  PA14 ∆*cco1cco2*-yfp                 LD2012   PA14 ∆*cco1cco2* constitutively expressing *eyfp*. Made by mating pAKN69 into LD1933.                                                                                                                                this study

  *Escherichia coli* strains                                                                                                                                                                                                                                         

  UQ950                                LD44     *E. coli* DH5 λpir strain for cloning. F-∆(argF- lac) 169φ80 dlacZ58(∆M15) glnV44(AS) rfbD1 gyrA96(NaIR) recA1 endA1 spoT thi-1 hsdR17 deoR λpir+                                                                    D. Lies, Caltech

  BW29427                              LD661    Donor strain for conjugation. thrB1004 pro thi rpsL hsdS lacZ ∆M15RP4-1360 ∆(araBAD)567\                                                                                                                             W. Metcalf, University of Illinois
                                                ∆dapA1314::\[erm pir(wt)\]                                                                                                                                                                                           

  β2155                                LD69     Helper strain. thrB1004 pro thi strA hsdsS lacZ∆M15 (F'lacZ∆M15 lacIq traD36 proA + proB + ) ∆dapA::erm (Ermr)pir::RP4 \[::kan (Kmr) from SM10\]                                                                     [@bib16]

  S17-1                                LD2901   StrR, TpR, F− RP4-2-Tc::Mu aphA::Tn7 recA λpir lysogen                                                                                                                                                               [@bib61]

  *Saccharomyces cerevisiae* strains                                                                                                                                                                                                                                 

  InvSc1                               LD676    MATa/MATalpha leu2/leu2 trp1-289/trp1-289 ura3−52/ura3-52 his3-∆1/his3-∆1                                                                                                                                            Invitrogen
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Construction of mutant *P. aeruginosa* strains {#s4-2}
----------------------------------------------

For making markerless deletion mutants in *P. aeruginosa* PA14 ([Table 1](#table1){ref-type="table"}) 1 kb of flanking sequence from each side of the target gene were amplified using the primers listed in [Table 2](#table2){ref-type="table"} and inserted into pMQ30 through gap repair cloning in *Saccharomyces cerevisiae* InvSc1 ([@bib60]). Each plasmid listed in [Table 3](#table3){ref-type="table"} was transformed into *Escherichia coli* strain UQ950, verified by restriction digests, and moved into PA14 using biparental conjugation. PA14 single recombinants were selected on LB agar plates containing 100 µg/ml gentamicin. Double recombinants (markerless deletions) were selected on LB without NaCl and modified to contain 10% sucrose. Genotypes of deletion mutants were confirmed by PCR. Combinatorial mutants were constructed by using single mutants as hosts for biparental conjugation, with the exception of *∆cco1cco2*, which was constructed by deleting the *cco1* and *cco2* operons simultaneously as one fragment. *ccoN4* complementation strains were made in the same manner, using primers LD438 and LD441 listed in [Table 2](#table2){ref-type="table"} to amplify the coding sequence of *ccoN4*, which was verified by sequencing and complemented back into the site of the deletion.
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###### Primers used in this study.

  --------------------------------------------------------------------------------------------------------------
  Primer number   Sequence                                                         used to make plasmid number
  --------------- ---------------------------------------------------------------- -----------------------------
  LD717           ccaggcaaattctgttttatcagaccgcttctgcgttctgatCAGGACAAGCAGTGGGAAC    pLD1852

  LD718           aggtgttgtaggccatcagcTGGCGGACCACCTTATAGTT                         

  LD958           aactataaggtggtccgccaCGGTGGTTTCTTCCTCACC                          

  LD959           ggaattgtgagcggataacaatttcacacaggaaacagctGGTCCAGCCTTTTTCCTTGT     

  LD725           ccaggcaaattctgttttatcagaccgcttctgcgttctgatCCCCTCAGAGAAGTCAGTCG   pLD1610

  LD726           aggtgttgtaggccatcaggGGCGGACCACCTTGTAGTTA                         

  LD727           taactacaaggtggtccgccCCTGATGGCCTACAACACCT                         

  LD728           ggaattgtgagcggataacaatttcacacaggaaacagctCAGCGGGTTGTCATACTCCT     

  LD741           ccaggcaaattctgttttatcagaccgcttctgcgttctgatTCGAGGGCTTCGAGAAGAT    pLD1616

  LD742           aggtgttgtaggccatcagcCAGGGTCATCAGGGTGAACT                         

  LD743           agttcaccctgatgaccctgGCTGATGGCCTACAACACCT                         

  LD744           ggaattgtgagcggataacaatttcacacaggaaacagctCGGGTGATGTCGACGTATTC     

  LD438           ggaattgtgagcggataacaatttcacacaggaaacagctCCGTTGATTTCCTTCTGCAT     pLD1264 (LD438 - LD441)\
                                                                                   pLD1853 (LD438 and LD441)

  LD439           ctacaaggtggttcgccagtCGCTGACCTACTCCTTCGTC                         

  LD440           gacgaaggagtaggtcagcgACTGGCGAACCACCTTGTAG                         

  LD441           ccaggcaaattctgttttatcagaccgcttctgcgttctgatCATCGACCTGGAAGTGCTC    

  LD725           ccaggcaaattctgttttatcagaccgcttctgcgttctgatCCCCTCAGAGAAGTCAGTCG   pLD1929

  LD1063          gttgcccaggtgttcctgtGGCGGACCACCTTGTAGTTA                          

  LD949           ggaattgtgagcggataacaatttcacacaggaaacagctTGTAGTCGAGGGACTTCTTGC    

  LD1064          taactacaaggtggtccgccACAGGAACACCTGGGCAAC                          

  LD2168          ccaggcaaattctgttttatcagaccgcttctgcgttctgatATGTAGGGATCGAGCGACAG   pLD2791

  LD2169          acacgatatccagcccctctTGGACATCGCGCCGTTCCTC                         

  LD2170          gaggaacggcgcgatgtccaAGAGGGGCTGGATATCGTGT                         

  LD2171          ggaattgtgagcggataacaatttcacacaggaaacagctAAGAGGTCATAATCGGCGGT     

  LD2120          gattcgacatcactagtACGCCCAGCTCCAACAAA                              pLD2777

  LD2121          gattcgatgccctcgaGCTAGGGGTTCCACGGTTAAT                            

  LD2122          gattcgactgcactagtCATCGACTTGCCGCCCAG                              pLD2778

  LD2123          g attcg atg ccctcgaGCTATGGGCTTCCATC CAC                          

  LD2124          gattcgactgcactagtGGCTACTTCCTCTGGCTGG                             pLD2779

  LD2125          gattcgactgcctcgagCTGTACAGTCCCGAAAGAAATGAAC                       

  LD1118          ccaggcaaattctgttttatcagaccgcttctgcgttctgatTCTTCAGGTTCTCGCGGTAG   pLD1966

  LD1119          aagtgccagtaccaactggcGCAGATCCAGAAGATGGTCA                         

  LD1120          tgaccatcttctggatctgcGCCAGTTGGTACTGGCACTT                         

  LD1121          ggaattgtgagcggataacaatttcacacaggaaacagctATCGCGAGACTCATGGTTTT     

  LD1134          ccaggcaaattctgttttatcagaccgcttctgcgttctgatCGCTGCTTGTCGATCTGTT    pLD1967

  LD1135          gcgacatgaccctgttcaacCTGACCGGCTACTGGACC                           

  LD1136          ggtccagtagccggtcagGTTGAACAGGGTCATGTCGC                           

  LD1137          ggaattgtgagcggataacaatttcacacaggaaacagctCCTCGGCGACCATGAATAC      

  LD1126          ccaggcaaattctgttttatcagaccgcttctgcgttctgatTTCAGGTTCTTCGGGTTCTC   pLD2044

  LD1187          aacagcgcgccgaccagcatCTCTTCGTTCGTTTTCAGCC                         

  LD1188          ggctgaaaacgaacgaagagATGCTGGTCGGCGCGCTGTT                         

  LD1189          ggaattgtgagcggataacaatttcacacaggaaacagctGCGTTGATGAAGCGGATAAC     
  --------------------------------------------------------------------------------------------------------------
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###### Plasmids used in this study.

  Plasmid   Description                                                                                                                                 Source
  --------- ------------------------------------------------------------------------------------------------------------------------------------------- ------------
  pMQ30     7.5 kb mobilizable vector; oriT, sacB, Gm^R^.                                                                                               [@bib60]
  pAKN69    Contains mini-Tn7(Gm)PA1/04/03::eyfp fusion.                                                                                                [@bib40]
  pLD2722   GmR, TetR flanked by Flp recombinase target (FRT) sites to resolve out resistance casettes.                                                 this study
  pFLP2     Site-specific excision vector with cI857-controlled FLP recombinase encoding sequence, sacB, Ap^R^.                                         [@bib30]
  pLD1852   ∆*ccoN1* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain InvSc1.                                                   this study
  pLD1610   ∆*ccoN2* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain InvSc1.                                                   this study
  pLD1616   ∆*ccoN3* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain InvSc1.                                                   this study
  pLD1264   ∆*ccoN4* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain InvSc1.                                                   this study
  pLD1929   ∆*cco1 cco2* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain InvSc1.                                               this study
  pLD2791   ∆*hcn* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain InvSc1.                                                     this study
  pLD1853   Full genomic sequence of *ccoN4* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain InvSc1. Verified by sequencing.   this study
  pLD1966   ∆*aa*3 PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain IncSc1.                                                     this study
  pLD1967   ∆*bo*3 PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain IncSc1.                                                     this study
  pLD2044   ∆*cio* PCR fragment introduced into pMQ30 by gap repair cloning in yeast strain IncSc1.                                                     this study
  pLD2777   PCR-amplified *cco1* promoter ligated into pSEK103 using SpeI and XhoI.                                                                     this study
  pLD2778   PCR-amplified *cco2* promoter ligated into pSEK103 using SpeI and XhoI.                                                                     this study
  pLD2779   PCR-amplified *ccoN4* promoter ligated into pSEK103 using SpeI and XhoI.                                                                    this study

Colony biofilm morphology assays {#s4-3}
--------------------------------

Overnight precultures were diluted 1:100 in LB (∆*N1*∆*N2*, ∆*N1*∆*N2*∆*N3*, ∆*N1*∆*N2*∆*N4*, ∆*N1*∆*N2*∆*N4*∆*N3*, ∆*N1*∆*N2*∆*N4::N4*, ∆*cco1cco2*, ∆*N1*∆*N2*∆*hcn*, ∆*N1*∆*N2*∆*N4*∆*hcn*, ∆*cco1cco2*∆*hcn*, and ∆*cox*∆*cyo*∆*cio* were diluted 1:50) and grown to mid-exponential phase (OD at 500 nm ≈ 0.5). Ten microliters of subcultures were spotted onto 60 ml of colony morphology medium (1% tryptone, 1% agar \[Teknova (Hollister, CA) A7777\] containing 40 µg/ml Congo red dye \[VWR (Radnor, PA) AAAB24310-14\] and 20 µg/ml Coomassie blue dye \[VWR EM-3300\]) in a 10 cm x 10 cm x 1.5 cm square Petri dish (LDP \[Wayne, NJ\] D210-16). For preparation of biofilms grown on on phenazine methosulfate (PMS), colony morphology medium was supplemented with 200 µM PMS (Amresco \[Solon, OH\] 0361) after autoclaving. For nitrate experiments, colony morphology medium was supplemented with 0, 10, or 40 mM potassium nitrate. Plates were incubated for up to 5 days at 25˚C with \>90% humidity (Percival \[Perry, IA\] CU-22L) and imaged daily using a VHX-1000 digital microscope (Keyence, Japan). Images shown are representative of at least 10 biological replicates. 3D images of biofilms were taken on day 5 of development using a Keyence VR-3100 wide-area 3D measurement system. ∆*cox*∆*cyo*∆*cio*, *hcn* deletion mutants, and strains grown for the nitrate experiment were imaged using a flatbed scanner (Epson \[Japan\] E11000XL-GA) and are representative of at least three biological replicates

TTC reduction assay {#s4-4}
-------------------

One microliter of overnight cultures (five biological replicates), grown as described above, was spotted onto a 1% tryptone, 1.5% agar plate containing 0.001% (w/v) TTC (2,3,5-triphenyl-tetrazolium chloride \[Sigma-Aldrich (St. Louis, MO) T8877\]) and incubated in the dark at 25˚C for 24 hr. Spots were imaged using a scanner (Epson E11000XL-GA) and TTC reduction, normalized to colony area, was quantified using Adobe Photoshop CS5 (San Jose, CA). Colorless TTC undergoes an irreversible color change to red when reduced. Pixels in the red color range were quantified and normalized to colony area using Photoshop CS5.

Liquid culture growth assays {#s4-5}
----------------------------

\(i\) Overnight precultures were diluted 1:100 (∆*N1*∆*N2*, ∆*N1*∆*N2*∆*N4*, and ∆*cco1cco2* were diluted 1:50) in 1% tryptone in a clear- flat-bottom polystyrene 96-well plate (VWR 82050--716) and grown for two hours (OD~500nm~ ≈ 0.2). These cultures were then diluted 100-fold in 1% tryptone in a new 96-well plate and incubated at 37°C with continuous shaking on the medium setting in a Synergy 4 plate reader (BioTek, Winooski, VT). Growth was assessed by taking OD readings at 500 nm every 30 min for at least 24 hr. (ii) *hcn* mutants: Overnight precultures were diluted 1:100 (∆*N1*∆*N2*∆*hcn*, ∆*N1*∆*N2*∆*N4*∆*hcn*, and ∆*cco1cco2*∆*hcn* were diluted 1:50) in MOPS minimal medium (50 mM 4-morpholinepropanesulfonic acid (pH 7.2), 43 mM NaCl, 93 mM NH~4~Cl, 2.2 mM KH~2~PO4, 1 mM MgSO~4~•7H~2~O, 1 µg/ml FeSO~4~•7H~2~O, 20 mM sodium succinate hexahydrate) and grown for 2.5 hr until OD at 500 nm ≈ 0.1. These cultures were then diluted 100-fold in MOPS minimal medium in a clear, flat-bottom polystyrene 96-well plate and incubated at 37°C with continuous shaking on the medium setting in a plate reader. Growth was assessed by taking OD readings at 500 nm every 30 min for at least 24 hr. (iii) Terminal oxidase reporters: Overnight precultures were grown in biological triplicate; each biological triplicate was grown in technical duplicate. Overnight precultures were diluted 1:100 in 1% tryptone and grown for 2.5 hr until OD at 500 nm ≈ 0.1. These cultures were then diluted 100-fold in 1% tryptone in a clear, flat-bottom, polystyrene black 96-well plate (VWR 82050--756) and incubated at 37°C with continuous shaking on the medium setting in a plate reader. Expression of GFP was assessed by taking fluorescence readings at excitation and emission wavelengths of 480 nm and 510 nm, respectively, every hour for 24 hr. Growth was assessed by taking OD readings at 500 nm every 30 min for 24 hr. Growth and RFU values for technical duplicates were averaged to obtain the respective values for each biological replicate. RFU values for a strain without a promoter inserted upstream of the *gfp* gene (MCS-*gfp*) were considered background and subtracted from the fluorescence values of each reporter.

Competition assays {#s4-6}
------------------

Overnight precultures of fluorescent (YFP-expressing) and non-fluorescent strains were diluted 1:100 in LB (∆*N1*∆*N2*, ∆*N1*∆*N2*∆*N4* and ∆*cco1cco2* were diluted 1:50) and grown to mid-exponential phase (OD at 500 nm ≈ 0.5). Exact OD at 500 nm values were read in a Spectronic 20D+ spectrophotometer (Thermo Fisher Scientific \[Waltham, MA\]) and cultures were adjusted to the same OD. Adjusted cultures were then mixed in a 1:1 ratio of fluorescent:non-fluorescent cells and 10 µl of this mixture were spotted onto colony morphology plates and grown for 3 days as described above. At specified time points, biofilms were collected, suspended in 1 ml of 1% tryptone, and homogenized on the 'high' setting in a bead mill homogenizer (Omni \[Kennesaw, GA\] Bead Ruptor 12); day 1 colonies were homogenized for 35 s while days 2 and 3 colonies were homogenized for 99 s. Homogenized cells were serially diluted and 10^−6^, 10^−7^, and 10^−8^ dilutions were plated onto 1% tryptone plates and grown overnight at 37°C. Fluorescent colony counts were determined by imaging plates with a Typhoon FLA7000 fluorescent scanner (GE Healthcare Life Sciences \[United Kingdom\]) and percentages of fluorescent vs. non-fluorescent colonies were determined.

Construction of terminal oxidase reporters {#s4-7}
------------------------------------------

Translational reporter constructs for the Cco1, Cco2, and CcoN4Q4 operons were constructed using primers listed in [Table 1](#table1){ref-type="table"}. Respective primers were used to amplify promoter regions (500 bp upstream of the operon of interest), adding an SpeI digest site to the 5' end of the promoter and an XhoI digest site to the 3' end of the promoter. Purified PCR products were digested and ligated into the multiple cloning site (MCS) of the pLD2722 vector, upstream of the *gfp* sequence. Plasmids were transformed into *E. coli* strain UQ950, verified by sequencing, and moved into PA14 using biparental conjugation with *E. coli* strain S17-1. PA14 single recombinants were selected on M9 minimal medium agar plates (47.8 mM Na~2~HPO~4~•7H~2~O, 22 mM KH~2~PO~4~, 8.6 mM NaCl, 18.6 mM NH~4~Cl, 1 mM MgSO~4~, 0.1 mM CaCl~2~, 20 mM sodium citrate dihydrate, 1.5% agar) containing 100 µg/ml gentamicin. The plasmid backbone was resolved out of PA14 using Flp-FRT recombination by introduction of the pFLP2 plasmid ([@bib30]) and selected on M9 minimal medium agar plates containing 300 µg/ml carbenicillin and further on LB agar plates without NaCl and modified to contain 10% sucrose. The presence of *gfp* in the final clones was confirmed by PCR.

Thin sectioning analyses {#s4-8}
------------------------

Two layers of 1% tryptone with 1% agar were poured to depths of 4.5 mm (bottom) and 1.5 mm (top). Overnight precultures were diluted 1:100 (∆*N1*∆*N2*, ∆*N1*∆*N4*, ∆*N1*∆*N2*∆*N4,* ∆*cco1cco2* were diluted 1:50) in LB and grown for 2 hr, until early-mid exponential phase. Five to 10 µl of subculture were then spotted onto the top agar layer and colonies were incubated in the dark at 25˚C with \>90% humidity (Percival CU-22L) and grown for up to 3 days. At specified time points to be prepared for thin sectioning, colonies were covered by a 1.5-mm-thick 1% agar layer. Colonies sandwiched between two 1.5-mm agar layers were lifted from the bottom layer and soaked for 4 hr in 50 mM L-lysine in phosphate buffered saline (PBS) (pH 7.4) at 4˚C, then fixed in 4% paraformaldehyde, 50 mM L-lysine, PBS (pH 7.4) for 4 hr at 4˚C, then overnight at 37°C. Fixed colonies were washed twice in PBS and dehydrated through a series of ethanol washes (25%, 50%, 70%, 95%, 3 × 100% ethanol) for 60 min each. Colonies were cleared via three 60-min incubations in Histoclear-II (National Diagnostics \[Atlanta, GA\] HS-202) and infiltrated with wax via two separate washes of 100% Paraplast Xtra paraffin wax (Thermo Fisher Scientific 50-276-89) for 2 hr each at 55˚C, then colonies were allowed to polymerize overnight at 4˚C. Tissue processing was performed using an STP120 Tissue Processor (Thermo Fisher Scientific 813150). Trimmed blocks were sectioned in 10-µm-thick sections perpendicular to the plane of the colony using an automatic microtome (Thermo Fisher Scientific 905200ER), floated onto water at 45˚C, and collected onto slides. Slides were air-dried overnight, heat-fixed on a hotplate for 1 hr at 45˚C, and rehydrated in the reverse order of processing. Rehydrated colonies were immediately mounted in TRIS-Buffered DAPI:Fluorogel (Thermo Fisher Scientific 50-246-93) and overlaid with a coverslip. Differential interference contrast (DIC) and fluorescent confocal images were captured using an LSM700 confocal microscope (Zeiss, Germany). Each strain was prepared in this manner in at least biological triplicates.

Colony thickness measurements {#s4-9}
-----------------------------

Colonies were prepared for thin sectioning as described above, but growth medium was supplemented with 40 µg/ml Congo Red dye and 20 µg/ml Coomassie Blue dye. Colony height measurements were obtained from confocal DIC images using Fiji image processing software ([@bib58]).

Lectin staining {#s4-10}
---------------

Two-day-old colonies were prepared for thin sectioning as described above. Rehydrated colonies were post-stained in 100 µg/ml fluorescein-labeled *Wisteria floribunda* lectin (Vector Laboratories (Burlingame, CA) FL-1351) in PBS before being washed twice in PBS, mounted in TRIS-buffered DAPI and overlaid with a coverslip. Fluorescent confocal images were captured using an LSM700 confocal microscope (Zeiss).

Redox profiling of biofilms {#s4-11}
---------------------------

A 25-µm-tip redox microelectrode and external reference (Unisense \[Denmark\] RD-25 and REF-RM) were used to measure the extracellular redox state of day 2 (\~48 hr) biofilms (grown as for the colony biofilm morphology assays). The redox microelectrode measures the tendency of a sample to take up or release electrons relative to the reference electrode, which is immersed in the same medium as the one on which the sample is grown. The redox microelectrode was calibrated according to manufacturer's instructions using a two-point calibration to 1% quinhydrone in pH 4 buffer and 1% quinhydrone in pH 7 buffer. Redox measurements were taken every 5 µm throughout the depth of the biofilm using a micromanipulator (Unisense MM33) with a measurement time of 3 s and a wait time between measurements of 5 s. Profiles were recorded using a multimeter (Unisense) and the SensorTrace Profiling software (Unisense).

Oxygen profiling of biofilms {#s4-12}
----------------------------

A 25-µm-tip oxygen microsensor (Unisense OX-25) was used to measure oxygen concentrations within biofilms during the first 2 days of development, grown as described above. For oxygen profiling on 3-day-old colonies ([Figure 4](#fig4){ref-type="fig"}), biofilms were grown as for the thin sectioning analyses. To calibrate the oxygen microsensor, a two-point calibration was used. The oxygen microsensor was calibrated first to atmospheric oxygen using a calibration chamber (Unisense CAL300) containing water continuously bubbled with air. The microsensor was then calibrated to a 'zero' point using an anoxic solution of water thoroughly bubbled with N~2~; to ensure complete removal of all oxygen, N~2~ was bubbled into the calibration chamber for a minimum of 30 min before calibrating the microsensor to the zero calibration point. Oxygen measurements were then taken throughout the depth of the biofilm using a measurement time of 3 s and a wait time between measurements of 5 s. For 6-hr-old colonies, a step size of 1 µm was used to profile through the entire colony; for 12 hr and 24 hr colonies, 2 µm; for 48 hr colonies, 5 µm. A micromanipulator (Unisense MM33) was used to move the microsensor within the biofilm and profiles were recorded using a multimeter (Unisense) and the SensorTrace Profiling software (Unisense).

Phenazine quantification {#s4-13}
------------------------

Overnight precultures were diluted 1:10 in LB and spotted onto a 25 mm filter disk (pore size: 0.2 µm; GE Healthcare 110606) placed into the center of one 35 × 10 mm round Petri dish (VWR 25373-041). Colonies were grown for 2 days in the dark at 25˚C with \>90% humidity. After 2 days of growth, each colony (with filter disk) was lifted off its respective plate and weighed. Excreted phenazines were then extracted from the agar medium overnight in 5 ml of 100% methanol (in the dark, nutating at room temperature). Three hundred µl of this overnight phenazine/methanol extraction were then filtered through a 0.22 µm cellulose Spin-X column (Thermo Fisher Scientific 07-200-386) and 200 µl of the flow-through were loaded into an HPLC vial. Phenazines were quantified using high-performance liquid chromatography (Agilent \[Santa Clara, CA\] 1100 HPLC System) as described previously ([@bib18]; [@bib57]).

*C. elegans* pathogenicity (slow killing) assays {#s4-14}
------------------------------------------------

Slow killing assays were performed as described previously ([@bib62]; [@bib48]). Briefly, 10 µl of overnight PA14 cultures (grown as described above) were spotted onto slow killing agar plates (0.3% NaCl, 0.35% Bacto-Peptone, 1 mM CaCl~2~, 1 mM MgSO~4~, 5 µg/ml cholesterol, 25 mM KPO~4~, 50 µg/ml FUDR, 1.7% agar) and plates were incubated for 24 hr at 37°C followed by 48 hr at room temperature (\~23°C). Larval stage 4 (L4) nematodes were picked onto the PA14-seeded plates and live/dead worms were counted for up to four days. Each plate was considered a biological replicate and had a starting sample size of 30--35 worms.

Statistical analysis {#s4-15}
--------------------

Data analysis was performed using GraphPad Prism version 7 (GraphPad Software, La Jolla, CA). Values are expressed as mean ±SD. Statistical significance of the data presented was assessed with the two-tailed unpaired Student's t-test. Values of p≤0.05 were considered significant (\*p≤0.05; \*\*p≤0.01; \*\*\*p≤0.001; \*\*\*\*p≤0.0001). Full statistical reporting for relevant figures can be found in [Table 4](#table4){ref-type="table"}.

10.7554/eLife.30205.019

###### Statistical analysis.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [Figure 2B](#fig2){ref-type="fig"}                           Number of values (biological replicates)       mean              median       SD         SEM         Lower 95% confidence interval of mean       Upper 95% confidence interval of mean
  ------------------------------------------------------------ ---------------------------------------------- ----------------- ------------ ---------- ----------- ------------------------------------------- -------------------------------------------
  WT                                                           5                                              73.22             72.94        3.387      1.515       69.02                                       77.43

  ∆*N4*                                                        5                                              68.97             70.6         6.44       2.88        60.97                                       76.96

  ∆*N1*∆*N2*                                                   5                                              52.18             50.46        5.142      2.3         45.79                                       58.56

  ∆*N1*∆*N4*                                                   5                                              11.57             12.42        2.011      0.8991      9.074                                       14.07

  ∆*N1*∆*N2*∆*N4*                                              5                                              0.001958          0.001117     0.001696   0.0007586   −0.0001481                                  0.004064

  ∆*cco1cco2*                                                  5                                              0.001367          0.0008644    0.001237   0.0005532   −0.0001686                                  0.002903

  t-test                                                       p value                                        p value summary                                                                                   

  WT vs. ∆*N4*                                                 0.2273                                         ns                                                                                                

  WT vs. ∆*N1*∆*N2*                                            \<0.0001                                       \*\*\*\*                                                                                          

  WT vs. ∆*N1*∆*N4*                                            \<0.0001                                       \*\*\*\*                                                                                          

  WT vs. ∆*N1*∆*N2*∆*N4*                                       \<0.0001                                       \*\*\*\*                                                                                          

  WT vs. ∆*cco1cco2*                                           \<0.0001                                       \*\*\*\*                                                                                          

  [Figure 3A](#fig3){ref-type="fig"}                           **Number of values (biological replicates)**   **mean**          **median**   **SD**     **SEM**     **Lower 95% confidence interval of mean**   **Upper 95% confidence interval of mean**

  WT-YFP                                                       12                                             54.95             54.92        4.387      1.266       52.16                                       57.74

  ∆*N4*-YFP                                                    3                                              29.92             30.83        2.234      1.29        24.37                                       35.46

  ∆*N1*∆*N2*-YFP                                               3                                              30.49             31.91        3.527      2.036       21.73                                       39.25

  ∆*N1*∆*N2*∆*N4*-YFP                                          3                                              4.408             4.296        3.23       1.865       −3.617                                      12.43

  ∆*cco1cco2*-YFP                                              3                                              7.097             5.306        4.093      2.363       −3.072                                      17.27

  t-test                                                       p value                                        p value summary                                                                                   

  WT-YFP vs. ∆*N4*- YFP                                        \<0.0001                                       \*\*\*\*                                                                                          

  WT-YFP vs.\                                                  \<0.0001                                       \*\*\*\*                                                                                          
  ∆*N1*∆*N2*-YFP                                                                                                                                                                                                

  ∆*N1*∆*N2*-YFP vs.\                                          0.0007                                         \*\*\*                                                                                            
  ∆*N1*∆*N2*∆*N4*-YFP                                                                                                                                                                                           

  ∆*N1*∆*N2*-YFP vs.\                                          0.0017                                         \*\*                                                                                              
  ∆*cco1cco2*-YFP                                                                                                                                                                                               

  [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}   **Number of values (biological replicates)**   **mean**          **median**   **SD**     **SEM**     **Lower 95% confidence interval of mean**   **Upper 95% confidence interval of mean**

  WT)                                                          12                                             45.05             45.08        4.387      1.266       42.26                                       47.84

  ∆*N4*                                                        3                                              28.22             31.31        7.442      4.297       9.731                                       46.71

  ∆*N1*∆*N2*                                                   3                                              27.81             28.57        2.514      1.451       21.56                                       34.05

  ∆*N1*∆*N2*∆*N4*                                              3                                              7.002             6.973        0.7508     0.4335      5.137                                       8.867

  ∆*cco1cco2*                                                  3                                              5.38              4.183        2.146      1.239       0.05034                                     10.71

  t-test                                                       p value                                        p value summary                                                                                   

  WT vs. ∆*N4*                                                 0.0002                                         \*\*\*                                                                                            

  WT vs. ∆*N1*∆*N2*                                            \<0.0001                                       \*\*\*\*                                                                                          

  ∆*N1*∆*N2* vs.\                                              0.0002                                         \*\*\*                                                                                            
  ∆*N1*∆*N2*∆*N4*                                                                                                                                                                                               

  ∆*N1*∆*N2* vs.\                                              0.0003                                         \*\*\*                                                                                            
  ∆*cco1cco2*                                                                                                                                                                                                   

  [Figure 5](#fig5){ref-type="fig"}                            **Number of values (biological replicates)**   **mean**          **median**   **SD**     **SEM**     **Lower 95% confidence interval of mean**   **Upper 95% confidence interval of mean**

  WT                                                           8                                              150.3             151.2        10.31      3.644       141.7                                       158.9

  ∆*N1*∆*N2*                                                   4                                              139.3             137.6        12.33      6.166       119.6                                       158.9

  ∆*N4*                                                        7                                              131.9             127.8        8.915      3.369       123.7                                       140.2

  ∆*N1*∆*N4*                                                   4                                              99.96             99.34        2.726      1.363       95.62                                       104.3

  ∆*cco1cco2*                                                  4                                              95.19             95.56        1.559      0.7793      92.71                                       97.67

  ∆*N1*∆*N2*∆*N4*                                              4                                              102.8             99.79        8.664      4.332       88.98                                       116.6

  ∆*phz*                                                       7                                              84.98             84.23        10.93      4.131       74.87                                       95.09

  t-test                                                       p value                                        p value summary                                                                                   

  WT vs. ∆*N1*∆*N2*                                            0.1302                                         ns                                                                                                

  WT vs. ∆*N4*                                                 0.0028                                         \*\*                                                                                              

  WT vs. ∆*N1*∆*N4*                                            \<0.0001                                       \*\*\*\*                                                                                          

  WT vs. ∆*cco1cco2*                                           \<0.0001                                       \*\*\*\*                                                                                          

  WT vs. ∆*N1*∆*N2*∆*N4*                                       \<0.0001                                       \*\*\*\*                                                                                          

  WT vs. ∆*phz*                                                \<0.0001                                       \*\*\*\*                                                                                          

  [Figure 6](#fig6){ref-type="fig"}                            **Number of values (biological replicates)**   **mean**          **median**   **SD**     **SEM**     **Lower 95% confidence interval of mean**   **Upper 95% confidence interval of mean**

  WT                                                           9                                              27.44             39           18.48      6.16        13.24                                       41.65

  *gacA::Tn*                                                   9                                              92.56             93           8.546      2.849       85.99                                       99.12

  ∆*N1*∆*N2*                                                   4                                              19                21.5         14.07      7.036       −3.39                                       41.39

  ∆*N1*∆*N2*∆*N4*                                              6                                              64.17             68           18         7.35        45.27                                       83.06

  ∆*cco1cco2*                                                  9                                              70.56             76           22.69      7.565       53.11                                       88

  t-test                                                       p value                                        p value summary                                                                                   

  WT vs. ∆*N1*∆*N2*∆*N4*                                       0.0022                                         \*\*                                                                                              

  ∆*N1*∆*N2* vs.\                                              0.0030                                         \*\*                                                                                              
  ∆*N1*∆*N2*∆*N4*                                                                                                                                                                                               

  WT vs. ∆*N1*∆*N2*                                            0.4362                                         ns                                                                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Decision letter

Donohue

Tim

Reviewing Editor

University of Wisconsin-Madison

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for sending your article entitled \"An orphan *cbb~3~*-type cytochrome oxidase subunit supports *Pseudomonas aeruginosa* biofilm growth and virulence\" for peer review at *eLife*. Your work has been evaluated by a Senior Editor, a Reviewing Editor and three reviewers.

Overall, the three outside reviews are supportive of publication of this contribution in *eLife*. Each of the reviewers mention the importance of this work and the overall quality of the presentation.

However, each of the reviewers has suggestions for improving the manuscript. While most of the suggestions ask for more discussion of issues in the text or changes to figures (that might not warrant new experiments), they do require significant clarification on important issues. These changes are needed either to clarify the paper for the readers or to make it clear what one can and cannot conclude form the data presented. Some examples are highlighted below.

One reviewer asks if there is additional evidence to support a direct interaction between CcoN4 and either Cco1 or Cco2. Hirai et al. 2016 indicate that *Pseudomonas* harbors 4 genes for subunit N (*ccoN1, N2, N3* and *N4*), 2 genes for subunit P (*ccoP1, P2*) and 2 genes for subunit O (*ccoO1, O2*), so it can theoretically produce 16 unique *cbb~3~* complexes (4N \* 2P \* 2O = 16 NPO), each containing an N subunit, a P subunit and an O subunit (www.pnas.org/cgi/doi/10.1073/pnas.1613308113). This 2016 paper claims to provide evidence that 16 different *cbb~3~* isoforms form in the *Pseudomonas* cell, i.e. all of the subunits can mix and match in the membrane to make 16 possible NPO combinations, each one a functional *cbb~3~*. If this is correct the \"direct interaction between CcoN4 and either Cco1 or Cco2\" asked for in the review has been demonstrated by Hirai et al., 2016, in that subunit N4 can complex with P1 and O1 from the cco1 operon and with P2 and O2 from the cco2 operon. A statement on this important issue should be included in the text.

Several reviewers raised the concern that the explanation of the *Pseudomonas cbb~3~* system will leave some readers confused. Reviewer 1 comments 1 and 2 are examples of where clarification would be beneficial. How does this system of multiple complexes work? Reviewer 1 comments 3 and 4 on the proposed reduction of phenazine by N4 make a key point for this study. In addition, reviewer 2 correctly states \"the authors do need to be clear that their data are consistent with the view that the N4 subunit confers the ability to reduce phenazines -- without purification of a Cco complex containing N4 there is no direct biochemical evidence that this is the case.\" Their hypothesis requires this test, but unless you have the data in hand it seems a stretch to require that you do this for this paper. However, it seems relatively simple to test whether the addition of a reducing agent reverses the biofilm phenotypes of the mutants (reviewer 3).

Before advising further and reaching a decision, we would like to hear your response to the concerns, along with an estimated time frame for completing any additional work and providing a point by point response to each of the comments of the reviewers.

Reviewer \#1:

In An orphan *cbb~3~*-type cytochrome oxidase subunit supports *Pseudomonas aeruginosa* biofilm growth and virulence, Jo et al. establish a role for the orphan *cbb~3~*-type terminal oxidase subunit, CcoN4, in colony biofilm development. The Pseudomonads have the unique characteristic of encoding multiple orphan *cbb~3~*-type subunits, but the function of the orphan subunits has remained elusive. In this study, Jo et al., reveal the CcoN4 orphan subunit functions during colony biofilm formation, as a *ccoN4* mutant demonstrates an altered colony biofilm morphology. The authors provide genetic evidence that the altered morphology resulting from the inactivation of *ccoN4* is likely due to Cco1-CcoN4 or Cco2-CcoN4 interactions by showing that a *cco1 cco2* double mutant has an exacerbated phenotype that is phenocopied in a triple mutant inactivated for *ccoN1, ccoN2*, and *ccoN4*. The importance of CcoN4 to colony biofilm growth is further established in the result that strains harboring a functioning CcoN4 outcompete *ccoN4* mutants when oxygen becomes limited during growth in a colony biofilm growth. The phenotypes associated with ccoN4 are specific to growth in a colony biofilm because *ccoN4* mutants do not exhibit altered growth in aerated broth culture. The finding that *ccoN4* expression coincides with both *cco1* and *cco2* throughout the depth of the biofilm provides further support for the hypothesis that CcoN4 interacts with Cco1 and Cco2. *P. aeruginosa* produces cyanide, a respiratory poison that targets terminal oxidase activity and previous reports implicate CcoN4 in resistance to cyanide. However, Jo et al. demonstrate that cyanide production does not affect the *ccoN4*-dependent phenotypes. Instead, the authors provide compelling evidence that the *ccoN4* altered colony biofilm morphology is due to an impaired capacity to reduce phenazines. The amount of phenazines produced by the *cco* mutants is a not considerably different; however, Jo et al. show that reduction of phenazines is impaired in a CcoN4-dependent manner leading to the conclusion that CcoN4 is important for the reduction of phenazines. In a *Caenorhabditis elegans* model of infection, CcoN4 isoform expression of the cbb3-type cytochrome oxidase mutants is required for virulence, supporting a role for CcoN4 in *P. aeruginosa* pathogenesis. This well-reasoned and well-written manuscript would be of interest to the *eLife* readership. The following suggestions serve as potential improvements manuscript:

1\) The evidence that CcoN4 functions through interaction with Cco1 or Cco2 is compelling. However, a direct Cco1-CcoN4 or Cco2-CcoN4 interaction within the colony biofilm will provide additional support for this hypothesis.

2\) Alternatively, does CcoN4 contain a unique domain(s) compared to CcoN1, CcoN2 and CcoN3 that facilitates an interaction with Cco1 or Cco2? An amino acid alignment of the four CcoN subunits would help the reader visualize unique domains within CcoN4 that might be responsible for the phenotype. Consistent with this, are *ccoN4* homologues from other species that contain multiple orphan *cbb~3~*-type subunits able to complement the PA14 *ccoN4* mutant phenotype? In total, these data will refine the molecular nature of the CcoN4 subunit and add further support that interactions between CcoN4 and Cco1 or Cco2 play an important role during colony biofilm growth.

3\) Does the amino sequence alignment of the CcoN subunits reveal potential phenazine interaction motifs within CcoN4? Amino acid sequence comparisons of CcoN4 proteins in Pseudomonads that harbor a *phz* homologue versus those that do not would be of particular interest.

4\) The colony biofilm phenotype of the phenazine knockout is remarkably similar to the *ccoN4* mutant but considerably different compared to the *cco1 cco2* and Δ*N1* Δ*N2* Δ*N4* mutants. Jo et al. show that the thickness is the same between these mutant colony biofilms is roughly the same. The authors propose that impaired phenazine reduction is responsible for the colony biofilm of *cco1 cco2* and Δ*N1* Δ*N2* Δ*N4*. Consistent with this model, one would surmise that the *phz* mutant colony biofilm phenotype should be dominant to the *cco1 cco2* and Δ*N1* Δ*N2* Δ*N4* colony biofilm phenotypes. Simply put, how does inactivation of *phz* in the *cco1 cco2* double mutant background and the Δ*N1* Δ*N2* Δ*N4* triple mutant background affect the colony biofilm phenotype? Does adding a reducing agent reverse the phenotypes (macroscopic or thickness) of the *cco1 cco2* and Δ*N1* Δ*N2* Δ*N4* mutants?

Reviewer \#2:

This manuscript makes an important contribution to understanding the apparent redundancy in *cbb~3~*subunits in *Pseudomonas aeruginosa*. The authors convincingly demonstrate that the CcoN4 subunit is critical for optimal biofilm formation and that this is a consequence of its ability to reduce phenazines. The data are clearly described in the figures and support the major conclusions. However, the authors do need to be clear that their data are consistent with the view that the N4 subunit confers the ability to reduce phenazines -- without purification of a Cco complex containing N4 there is no direct biochemical evidence that this is the case.

Reviewer \#3:

The authors have analyzed *Pseudomonas aeruginosa* cells that contain different versions of the *cbb~3~*-type CcO with different isoforms of subunit 1 (N). The paper contains significant information that should be published. I have worked to identify points that the authors could revise in order to help readers learn more from the data.

1\) The report is focused on the *cbb~3~* oxidase containing subunit N4. However, the *cbb~3~* containing N1 seems to have nearly equal impact, while N2 and N3 have less. Restricting the conclusions to N4 limits impact, and it may be misleading. For example, in the last paragraph of the subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration", the authors state that CcON4 *cbb~3~* is used preferentially in biofilm, in comparison to CcO N1. This does not appear to be true, the two things unique to N4 and not N1 are a colony morphology and the apparent requirement for N4 to kill *C. elegans*. Otherwise the results for N1 and N4 are similar.

2\) Apparently all of the deletion strains retain other types of terminal oxidases, including a *bo~3~*-type and a *bd*-type quinol oxidase plus an *aa~3~*-type cytochrome *c* oxidase. This should be discussed.

3\) Colony morphology is emphasized, but the relationship of the colony to biofilm is not adequately explained. Is all of the colony biofilm? Are the ridges and the rings that project upwards in various colonies composed of cells that are growing outside of the biofilm? A diagram of a colony labeling the different zones would help. Is there any physiological explanation for the ridges and rings?

4\) The requirement for *cbb~3~* oxidases for the reduction of phenazine compounds (subsection "Microelectrode-based redox profiling reveals differential phenazine reduction activity in wild-type and cco mutant biofilms", second paragraph) is interesting but not well discussed. The explanations in the fifth paragraph of the Discussion are too vague given known CcO biochemistry. A direct interaction of phenazine with *cbb3* seems likely. Phenazines are highly unlikely to be reduced at the O2 reduction site of subunit N due to their size. However, phenazines are known to interact directly with CcOs in that these compounds are used as electron mediators to reduce cytochrome *c* when cytochrome *c* is bound to CcOs. Increased levels of reduced cytochrome *c* in the hypoxic zone may reduce phenazines at the cytochrome *c* binding site of CcOs. While the cytochrome *c* binding sites are not present on subunits N, different isoforms of N may enhance phenazine reduction at cytochrome *c* binding sites on CcOP or O. The *aa~3~*-type CcO should be capable of the same reaction.

5\) The third paragraph of the Discussion is confusing. It begins with a proposal that N4 does not form heterocomplexes with the P and O subunits of CcO1 and CcO2. However, such heterocomplexes have already been demonstrated by Hirai et al., 2016.

6\) In the first paragraph of the subsection "*cco* genes show differential expression across biofilm subzones", the third and fifth paragraphs of the Discussion and elsewhere we read that *cbb~3~* containing CcON4 (and N1) are produced throughout the biofilm, especially in the hypoxic zone. In the fourth paragraph of the Discussion, the authors state \"ccoN4Q4 is uniquely induced....in the upper portion of the biofilm where O2 is available...\" This apparent contradiction is confusing.

10.7554/eLife.30205.022

Author response

> Reviewer \#1: \[...\] 1) The evidence that CcoN4 functions through interaction with Cco1 or Cco2 is compelling. However, a direct Cco1-CcoN4 or Cco2-CcoN4 interaction within the colony biofilm will provide additional support for this hypothesis.

We agree that direct interactions of CcoN4 with Cco1 and Cco2 are fundamental to our conclusions. Hirai et al. (2016, doi: 10.1073/pnas.1613308113) previously demonstrated formation of these heterologous Cco isoforms biochemically. We provide genetic evidence that further supports their findings and extends them to the biofilm mode of growth. While we had alluded to the formation of these complexes as shown by Hirai et al. (subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration", second paragraph, Discussion, second paragraph), we regret omitting a more detailed description and have added the appropriate text to the Introduction (fourth paragraph). These findings are also mentioned in the Results (subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration", second paragraph) and Discussion section, second paragraph.

> 2\) Alternatively, does CcoN4 contain a unique domain(s) compared to CcoN1, CcoN2 and CcoN3 that facilitates an interaction with Cco1 or Cco2? An amino acid alignment of the four CcoN subunits would help the reader visualize unique domains within CcoN4 that might be responsible for the phenotype. Consistent with this, are ccoN4 homologues from other species that contain multiple orphan cbb~3~-type subunits able to complement the PA14 ccoN4 mutant phenotype? In total, these data will refine the molecular nature of the CcoN4 subunit and add further support that interactions between CcoN4 and Cco1 or Cco2 play an important role during colony biofilm growth.

We agree that a sequence analysis comparing the CcoN subunits could provide insight into their differential contributions to colony morphogenesis. We now include an alignment in a new supplemental figure ([Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}), highlighting residues that are unique to CcoN4 or shared uniquely between CcoN4 and CcoN1, which showed the strongest functional redundancy with CcoN4 in our assays. To illustrate the structural arrangement of these residues, we threaded the CcoN4 sequence using the available structure of the CcoN subunit from *P. stutzeri* ([Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"}). We note in the text that "most of the highlighted residues are surface-exposed, specifically on one half of the predicted CcoN4 structure, where they may engage in binding an unknown protein partner or specific lipids. In contrast, sites that have been described as points of interaction with CcoO and CcoP are mostly conserved, further supporting the notion that CcoN4 can interact with these subunits in Cco complexes."

We feel that this sequence analysis, combined with our genetic evidence and the biochemical evidence previously reported by Hirai et al. (2016), provide a compelling case for direct interaction between CcoN4 and the Cco1/2 O and P subunits. We agree with the reviewer that questions regarding the functions of orphan N subunits in different organisms are interesting and hope to pursue these in the future.

> 3\) Does the amino sequence alignment of the CcoN subunits reveal potential phenazine interaction motifs within CcoN4? Amino acid sequence comparisons of CcoN4 proteins in Pseudomonads that harbor a phz homologue versus those that do not would be of particular interest.

We observe a strong phenazine reduction effect only when *ccoN*1 and *ccoN4* are both deleted ([Figure 5](#fig5){ref-type="fig"}), suggesting redundancy. Therefore, residues that are specifically shared between these subunits could be involved in mediating phenazine reduction. As outlined in our comments above, we now highlight these residues in [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"} and discuss this in the last paragraph of the subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration"

> 4\) The colony biofilm phenotype of the phenazine knockout is remarkably similar to the ccoN4 mutant but considerably different compared to the cco1 cco2 and ΔN1 ΔN2 ΔN4 mutants. Jo et al. show that the thickness is the same between these mutant colony biofilms is roughly the same. The authors propose that impaired phenazine reduction is responsible for the colony biofilm of cco1 cco2 and ΔN1 ΔN2 ΔN4. Consistent with this model, one would surmise that the phz mutant colony biofilm phenotype should be dominant to the cco1 cco2 and ΔN1 ΔN2 ΔN4 colony biofilm phenotypes. Simply put, how does inactivation of phz in the cco1 cco2 double mutant background and the ΔN1 ΔN2 ΔN4 triple mutant background affect the colony biofilm phenotype? Does adding a reducing agent reverse the phenotypes (macroscopic or thickness) of the cco1 cco2 and ΔN1 ΔN2 ΔN4 mutants?

The reviewer raises an important issue regarding the effects of a lack of phenazines or phenazine reduction vs. a lack of *cbb~3~*-type terminal oxidases. It has been established that Cco1 and Cco2 function as the main enzymes responsible for oxygen reduction in *P. aeruginosa* (Arai et al. (2014) doi: 10.1128/JB.02176-14). When Cco1 and Cco2 are deleted, cells not only lack the ability to reduce phenazines, as our data show, but are also defective in aerobic respiration. Furthermore, our data indicate a phenazine-independent role of the cbb~3~-type terminal oxidases and their associated CcoN subunits: while ∆*N4* and ∆*N1*∆*N2* show normal phenazine reduction ([Figure 5](#fig5){ref-type="fig"}), both of these strains exhibit fitness disadvantages compared to the wild type ([Figure 3](#fig3){ref-type="fig"}). These interwoven effects are most prominently seen in the dramatic morphological changes of ∆*cco1cco2* and ∆*N1*∆*N2*∆*N4* ([Figure 2A](#fig2){ref-type="fig"}). We would not expect removal of phenazines to overcome the oxygen-dependent effects. ∆*N4* and ∆*N1*∆*N4*, for which we demonstrated phenazine reduction defects, may be the mutants in which phenazine and oxygen reduction are best separated. As this is an important issue that requires clarification, we now also discuss it in the fourth and fifth paragraphs of the Discussion.

Our prior work has shown that phenazine reduction oxidizes the cellular redox state when electron acceptors such as oxygen are not accessible (Dietrich et al., 2013). However, the enzymes mediating this phenomenon were not known. Our results suggest that *cbb~3~*-type oxidases are required for coupling oxidation of the cytoplasm to phenazine reduction. Adding reductant would decouple phenazine reduction from cellular redox balancing and therefore would not be expected to reverse the phenotypes of *cco* mutants. However, in agreement with our model, addition of an alternative electron acceptor would be expected to reverse these phenotypes (i.e., inhibit wrinkling). We have performed this experiment with nitrate, which *P. aeruginosa* is able to use as an alternative electron acceptor (Williams et al. (2007) doi: 10.1016/S0065-2911(06)52001-6). We found that nitrate inhibited wrinkling of the various *cco* mutants. These results are included as a new panel in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and described in the last paragraph of the subsection "Microelectrode-based redox profiling reveals differential phenazine reduction activity in wild-type and *cco* mutant biofilms".

> Reviewer \#2:
>
> This manuscript makes an important contribution to understanding the apparent redundancy in cbb~3~ subunits in Pseudomonas aeruginosa. The authors convincingly demonstrate that the CcoN4 subunit is critical for optimal biofilm formation and that this is a consequence of its ability to reduce phenazines. The data are clearly described in the figures and support the major conclusions. However, the authors do need to be clear that their data are consistent with the view that the N4 subunit confers the ability to reduce phenazines -- without purification of a Cco complex containing N4 there is no direct biochemical evidence that this is the case.

We appreciate the reviewer's positive comments regarding our manuscript. We agree with the reviewer's comment that our genetic analyses support the hypothesis that the *cbb~3~*-type terminal oxidases, including the CcoN4-containing heterocomplex(es), reduce phenazines, but that biochemical data are ultimately required to directly show this enzymatic activity. We have added a statement in the main text to stress this (Discussion, sixth paragraph).

> Reviewer \#3:
>
> The authors have analyzed Pseudomonas aeruginosa cells that contain different versions of the cbb~3~-type CcO with different isoforms of subunit 1 (N). The paper contains significant information that should be published. I have worked to identify points that the authors could revise in order to help readers learn more from the data.
>
> 1\) The report is focused on the cbb~3~ oxidase containing subunit N4. However, the cbb~3~ containing N1 seems to have nearly equal impact, while N2 and N3 have less. Restricting the conclusions to N4 limits impact, and it may be misleading. For example, in the last paragraph of the subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration", the authors state that CcON4 cbb~3~ is used preferentially in biofilm, in comparison to CcO N1. This does not appear to be true, the two things unique to N4 and not N1 are a colony morphology and the apparent requirement for N4 to kill C. elegans. Otherwise the results for N1 and N4 are similar.

The reviewer is correct that our data suggest a lesser role for the CcoN2 and CcoN3 subunits in aerobically grown *P. aeruginosa* biofilms, as indicated by the various *cco* mutant phenotypes shown in [Figure 2A](#fig2){ref-type="fig"}. To further demonstrate this, we made the double mutants ∆*N2*∆*N4* and ∆*N3*∆*N4* and show that these mutants phenocopy the ∆*N4* single mutant ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}, subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration", second paragraph).

We agree that CcoN1 plays a significant role in the biofilm: Colony thickness and phenazine reduction are more affected in ∆*N1*∆*N4* colonies than ∆*N1* colonies. Considering that CcoN4 has no appreciable phenotype under the liquid culture conditions that we tested, we do find it noteworthy that only ∆*N4*, and not ∆*N1*∆*N2*, shows significant defects in colony thickness ([Figure 5B](#fig5){ref-type="fig"}) and the single ∆*N4* mutant has a more pronounced macroscopic biofilm phenotype than even the triple deletion mutant of the other three subunits, ∆*N1*∆*N2*∆*N3* ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}).

However, we acknowledge the importance of CcoN1 as our data make it clear that there is redundancy between this subunit and CcoN4. We now discuss this in the main text (subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration", second, third and last paragraphs) and also added, in response to reviewer 1, [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"} highlighting residues that are uniquely shared between CcoN1 and CcoN4.

> 2\) Apparently all of the deletion strains retain other types of terminal oxidases, including a bo~3~-type and a bd-type quinol oxidase plus an aa~3~-type cytochrome c oxidase. This should be discussed.

Yes, all deletion strains still contain the other three terminal oxidases (the *aa~3~*-type, the *bo~3~*-type, and CIO) and we appreciate the reviewer raising this point. We made a triple deletion of those terminal oxidases (∆*cox*∆*cyo*∆*cio*) and added [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"} and [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"} to show that this strain has a colony morphology and a redox profile that are similar to those of the wild type and have amended the text to incorporate these results (subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration", second paragraph and subsection "Microelectrode-based redox profiling reveals differential phenazine reduction activity in wild-type and *cco* mutant biofilms", second paragraph).

> 3\) Colony morphology is emphasized, but the relationship of the colony to biofilm is not adequately explained. Is all of the colony biofilm? Are the ridges and the rings that project upwards in various colonies composed of cells that are growing outside of the biofilm? A diagram of a colony labeling the different zones would help. Is there any physiological explanation for the ridges and rings?

We regret that we did not explicitly describe our approach to studying redox metabolism in biofilms and appreciate the reviewer pointing this out. A biofilm is a multicellular community that produces extracellular matrix; therefore, the entirety of the colony (including all wrinkle/ridge structures) is a biofilm. The structures that form, such as wrinkles and the high ring, result from the interplay of a variety of contributing factors but are mainly determined by (i) the distribution of cells in the initial droplet pipetted onto the plate and (ii) the production of extracellular matrix, which stimulates colony wrinkling. High central rings correspond to the circumference of the initial droplet and can be attributed in part to the "coffee ring effect" (Sempels et al. 2013). We have shown that matrix production is regulated in part by redox-sensing proteins that modulate intracellular signaling pathways (Okegbe et al. 2017), and suspect that the mutant phenotypes reported in this study could be modulated in this way. We have alluded to our work using the colony (biofilm) morphology assay to study redox metabolism and redox-driven community development in the fifth paragraph of the Introduction, the first paragraph of the subsection "CcoN4-containing isoforms function specifically in biofilms to support community morphogenesis and respiration" and the second paragraph of the Discussion.

> 4\) The requirement for cbb~3~ oxidases for the reduction of phenazine compounds (subsection "Microelectrode-based redox profiling reveals differential phenazine reduction activity in wild-type and cco mutant biofilms", second paragraph) is interesting but not well discussed. The explanations in the fifth paragraph of the Discussion are too vague given known CcO biochemistry. A direct interaction of phenazine with cbb3 seems likely. Phenazines are highly unlikely to be reduced at the O2 reduction site of subunit N due to their size. However, phenazines are known to interact directly with CcOs in that these compounds are used as electron mediators to reduce cytochrome c when cytochrome c is bound to CcOs. Increased levels of reduced cytochrome c in the hypoxic zone may reduce phenazines at the cytochrome c binding site of CcOs. While the cytochrome c binding sites are not present on subunits N, different isoforms of N may enhance phenazine reduction at cytochrome c binding sites on CcOP or O. The aa~3~-type CcO should be capable of the same reaction.

We thank the reviewer for raising this interesting point. The fact that phenazines are popular electron donors for biochemical studies of cytochrome oxidases does imply that these compounds can interact with the complex. We agree that different isoforms of N may indirectly enhance phenazine reduction at cytochrome c binding sites on CcoO or CcoP by affecting the overall structure of the complex. Furthermore, earlier reports have suggested that the cytochrome *bc~1~* complex is the site of phenazine reduction in isolated mitochondria (Armstrong and Stewart-Tull (1971) doi: 10.1099/00222615-4-2-263); if this is the case in *P. aeruginosa*, alterations in *cbb~3~* oxidase function may indirectly affect activity at other sites in the respiratory chain. While we have observed that phenazine reduction is influenced by the specific N subunit present in the *cbb~3~* oxidase isoform, at this stage we don't feel that we can speculate as to the exact site of phenazine reduction. We have added these points to the Discussion section (sixth paragraph).

> 5\) The third paragraph of the Discussion is confusing. It begins with a proposal that N4 does not form heterocomplexes with the P and O subunits of CcO1 and CcO2. However, such heterocomplexes have already been demonstrated by Hirai et al., 2016.

We agree that the wording of this paragraph was confusing and we have revised it to more accurately describe our results in the context of those reported in Hirai et al. (2016) (Discussion, third paragraph).

> 6\) In the first paragraph of the subsection "cco genes show differential expression across biofilm subzones", the third and fifth paragraphs of the Discussion and elsewhere we read that cbb~3~ containing CcON4 (and N1) are produced throughout the biofilm, especially in the hypoxic zone. In the fourth paragraph of the Discussion, the authors state \"ccoN4Q4 is uniquely induced....in the upper portion of the biofilm where O2 is available...\" This apparent contradiction is confusing.

Expression data from our reporter constructs show that CcoN4 is produced throughout the biofilm ([Figure 4](#fig4){ref-type="fig"}). In light of these results, the line pointed out by reviewer 3 does seem to be contradictory and warrants clarification. Our intent was to highlight that CcoN4 had been shown previously to be upregulated under low oxygen conditions in liquid culture and therefore its expression in well-oxygenated regions may be a biofilm-specific expression pattern. We have revised the text to better explain our conclusions (Discussion, fourth paragraph).
